{"id":43681,"date":"2015-09-17T11:25:58","date_gmt":"2015-09-17T16:25:58","guid":{"rendered":"https:\/\/content.findlaw-admin.com\/ability-legal\/contracts\/uncategorized\/stock-purchase-agreement-homestore-com-inc-fas-hotline-inc.html"},"modified":"2015-09-17T11:25:58","modified_gmt":"2015-09-17T16:25:58","slug":"stock-purchase-agreement-homestore-com-inc-fas-hotline-inc","status":"publish","type":"corporate_contracts","link":"https:\/\/corporate.findlaw.com\/contracts\/planning\/stock-purchase-agreement-homestore-com-inc-fas-hotline-inc.html","title":{"rendered":"Stock Purchase Agreement &#8211; Homestore.com Inc., FAS-Hotline, Inc. and Central Newspapers Inc."},"content":{"rendered":"<pre>                           STOCK PURCHASE AGREEMENT\n\n                                 BY AND AMONG\n\n                              HOMESTORE.COM, INC.\n\n                               FAS-HOTLINE, INC.\n\n                   THE SHAREHOLDERS OF THE FAS-HOTLINE, INC.\n\n                                      AND\n\n                           CENTRAL NEWSPAPERS, INC.,\n\n                             AS SHAREHOLDER AGENT\n\n                         Dated as of October 12, 1999\n\n \n                                                                    CONFIDENTIAL\n                                                                  EXECUTION COPY\n\n                               TABLE OF CONTENTS\n<\/pre>\n<table>\n<caption>\n                                                                                                     Page<br \/>\n                                                                                                     &#8212;-<br \/>\n<s>                                                                                                  <c><br \/>\nARTICLE 1. PURCHASE AND SALE OF THE SECURITIES&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;    2<\/p>\n<p>     1.1    Purchase and Sale of the Securities&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..    2<br \/>\n     1.2    Closing&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;    2<br \/>\n     1.3    Closing Deliveries&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.    3<br \/>\n     1.4    Further Assurances&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.    4<\/p>\n<p>ARTICLE 2. REPRESENTATIONS AND WARRANTIES OF FAS AND THE SHAREHOLDERS&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.    4<\/p>\n<p>     2.1    Organization of FAS&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;    4<br \/>\n     2.2    FAS Capital Structure&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.    5<br \/>\n     2.3    Obligations With Respect to Capital Stock&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..    6<br \/>\n     2.4    Authority; Non-Contravention&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;    6<br \/>\n     2.5    HBF Financial Statements&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.    7<br \/>\n     2.6    Absence of Certain Changes or Events&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.    8<br \/>\n     2.7    Taxes&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..    8<br \/>\n     2.8    Title to Properties; Absence of Liens and Encumbrances&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.   10<br \/>\n     2.9    Intellectual Property&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.   10<br \/>\n     2.10   Compliance; Permits; Restrictions&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.   13<br \/>\n     2.11   Litigation&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;   13<br \/>\n     2.12   Brokers&#8217; and Finders&#8217; Fees&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..   14<br \/>\n     2.13   Interested Party Transactions&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..   14<br \/>\n     2.14   Employee Benefit Plans&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;   14<br \/>\n     2.15   Environmental Matters&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.   18<br \/>\n     2.16   Year 2000 Compliance&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..   19<br \/>\n     2.17   Agreements, Contracts and Commitments&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;   19<br \/>\n     2.18   Insurance&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.   20<br \/>\n     2.19   Contingent Payment Arrangements&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;   21<\/p>\n<p>ARTICLE 3. REPRESENTATIONS AND WARRANTIES OF EACH SHAREHOLDER&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;   21<\/p>\n<p>     3.1    Ownership of Shares&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;   21<br \/>\n     3.2    Authority; Non-Contravention&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;   21<br \/>\n     3.3    Investment Representations&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..   22<\/p>\n<p>ARTICLE 4. REPRESENTATIONS AND WARRANTIES OF PURCHASER&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.   23<\/p>\n<p>     4.1    Authority; Non-Contravention&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;   23<br \/>\n     4.2    Organization of Purchaser&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;   24<br \/>\n     4.3    Purchaser SEC Filings; Financial Statements&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;   25<br \/>\n     4.4    No Material Adverse Change&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..   25<br \/>\n<\/c><\/s><\/caption>\n<\/table>\n<p>                                      -i-   <\/p>\n<p>                                                                    CONFIDENTIAL<br \/>\n                                                                  EXECUTION COPY<\/p>\n<p>                               TABLE OF CONTENTS<\/p>\n<table>\n<caption>\n                                                                                                     Page<br \/>\n                                                                                                     &#8212;-<br \/>\n<s>                                                                                                  <c><br \/>\n     4.5    Brokers&#8217; and Finders&#8217; Fees&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..   25<br \/>\n     4.6    Corporate Approvals&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;   25<br \/>\n     4.7    Share Issuance&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..   26<\/p>\n<p>ARTICLE 5. CONDUCT PRIOR TO THE CLOSING DATE&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..   26<\/p>\n<p>     5.1    Conduct of Business of FAS&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..   26<br \/>\n     5.2    Exclusivity&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..   28<\/p>\n<p>ARTICLE 6. ADDITIONAL AGREEMENTS&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..   29<\/p>\n<p>     6.1    Restrictions on Transfer&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.   29<br \/>\n     6.2    Access to Information&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.   30<br \/>\n     6.3    Confidentiality&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.   30<br \/>\n     6.4    Expenses&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..   30<br \/>\n     6.5    Public Disclosure&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..   30<br \/>\n     6.6    Consents&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..   30<br \/>\n     6.7    HSR Act&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;   30<br \/>\n     6.8    FIRPTA Compliance&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..   31<br \/>\n     6.9    Reasonable Efforts&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.   31<br \/>\n     6.10   Notification of Certain Matters&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;   31<br \/>\n     6.11   Cooperation of Independent Accountants&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..   32<br \/>\n     6.12   Employment Matters&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.   32<br \/>\n     6.13   Employment and Non-Competition Agreements&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..   32<br \/>\n     6.14   Contingent Payment Agreements&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..   32<br \/>\n     6.15   Director Resignations&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.   32<br \/>\n     6.16   Release&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;   32<br \/>\n     6.17   Termination of Employment, Contingent Payment and Buyback Arrangements&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;   34<br \/>\n     6.18   Morgan Stanley Consent&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;   34<\/p>\n<p>ARTICLE 7. CONDITIONS TO THE PURCHASE AND SALE OF THE SHARES&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.   34<\/p>\n<p>     7.1    Conditions to Obligations of the Parties&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;   34<br \/>\n     7.2    Conditions to Obligations of Purchaser&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..   35<br \/>\n     7.3    Conditions to the Obligations of the Shareholders&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;   36<\/p>\n<p>ARTICLE 8. SURVIVAL OF REPRESENTATIONS AND WARRANTIES&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..   37<\/p>\n<p>     8.1    Survival of Representations and Warranties&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.   37<br \/>\n     8.2    Indemnification&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.   37<br \/>\n<\/c><\/s><\/caption>\n<\/table>\n<p>                                     -ii-    <\/p>\n<p>                                                                    CONFIDENTIAL<br \/>\n                                                                  EXECUTION COPY<\/p>\n<p>                               TABLE OF CONTENTS                  <\/p>\n<table>\n<caption>\n                                                                                                     Page<br \/>\n                                                                                                     &#8212;-<br \/>\n<s>                                                                                                  <c><br \/>\nARTICLE 9. TERMINATION, AMENDMENT AND WAIVER&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..   40<\/p>\n<p>     9.1    Termination&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..   40<br \/>\n     9.2    Effect of Termination&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.   42<br \/>\n     9.3    Amendment&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.   42<br \/>\n     9.4    Extension; Waiver&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..   42<\/p>\n<p>ARTICLE 10. GENERAL PROVISIONS&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.   42<\/p>\n<p>     10.1   Notices&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;   42<br \/>\n     10.2   Interpretation&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..   44<br \/>\n     10.3   Counterparts&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.   44<br \/>\n     10.4   Entire Agreement; Assignment&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;   44<br \/>\n     10.5   Severability&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.   44<br \/>\n     10.6   Other Remedies&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;..   44<br \/>\n     10.7   Governing Law&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;   44<br \/>\n     10.8   Rules of Construction&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.   45<br \/>\n     10.9   Attorneys&#8217; Fees&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;&#8230;.   45<br \/>\n<\/c><\/s><\/caption>\n<\/table>\n<p>Exhibit A   Shareholders and Payments<br \/>\nExhibit B   Form of Promissory Note<br \/>\nExhibit C   Form of Employment and Non-Competition Agreement<br \/>\nExhibit D   Form of Non-Competition and Non-Solicitation Agreement<br \/>\nExhibit E   Form of Consulting and Non-Competition Agreement<br \/>\nExhibit F   Form of Pledge Agreement<br \/>\nExhibit G   List of Employees Signing Employment and Non-Competition Agreements<br \/>\nExhibit H   Form of Snell &amp; Wilmer L.L.P. Legal Opinion<br \/>\nExhibit I   Form of Fenwick &amp; West LLP Legal Opinion                   <\/p>\n<p>                                     -iii-<\/p>\n<p>                           STOCK PURCHASE AGREEMENT<\/p>\n<p>     This STOCK PURCHASE AGREEMENT (the &#8220;Agreement&#8221;) is made and entered into as<br \/>\nof October 12, 1999 by and among homestore.com, Inc., a Delaware corporation<br \/>\n(&#8220;Purchaser&#8221;), The FAS-Hotline, Inc., an Arizona corporation (&#8220;FAS&#8221;), the<br \/>\nshareholders of FAS as listed on Exhibit A hereto (collectively, the<br \/>\n&#8220;Shareholders&#8221; and each, a &#8220;Shareholder&#8221;) and, also with respect to Article 8,<br \/>\nCentral Newspapers, Inc., an Indiana corporation (&#8220;CNI&#8221;), as Shareholder Agent.<\/p>\n<p>                                   RECITALS<\/p>\n<p>     A.   The Shareholders own and will own all of the outstanding capital stock<br \/>\nof FAS (including all options, warrants and other rights to acquire capital<br \/>\nstock of FAS).<\/p>\n<p>     B.   Upon the terms and subject to the conditions hereof, the Shareholders<br \/>\nwish to sell to the Purchaser, and the Purchaser wishes to purchase from the<br \/>\nShareholders, all of the outstanding capital stock of FAS (including all<br \/>\noptions, warrants and other rights to acquire capital stock of FAS) for an<br \/>\naggregate purchase price of six million four hundred twelve thousand eight<br \/>\nhundred thirty dollars ($6,412,830.00) in cash to be paid at the Closing (as<br \/>\ndefined in Section 1.2 hereof), thirty three thousand and sixty two (33,062)<br \/>\nshares of common stock of the Purchaser to be issued at the Closing, and six<br \/>\nmillion nine hundred twenty two thousand nine hundred thirty two dollars<br \/>\n($6,922,932.00) principal amount in the form of secured subordinated promissory<br \/>\nnotes in the form attached hereto as Exhibit B (the &#8220;Notes&#8221;) to be delivered at<br \/>\nthe Closing.<\/p>\n<p>     C.   Purchaser shall have the right to set off a portion of the principal<br \/>\nand interest on the Notes for purposes of satisfying certain liabilities,<br \/>\ndamages, losses, expenses and other similar charges which result from a breach<br \/>\nof the representations, warranties, covenants and agreements of FAS and the<br \/>\nShareholders as set forth in Article 8.<\/p>\n<p>     D.   As a material inducement for Purchaser to purchase the capital stock<br \/>\nof FAS, certain key employees are entering into employment and non-competition<br \/>\nagreements in the form attached hereto as Exhibit C (the &#8220;Employment and Non-<br \/>\nCompetition Agreement&#8221;) with Purchaser, each of which shall become effective as<br \/>\nof the Closing.<\/p>\n<p>     E.   As a material inducement for Purchaser to purchase the capital stock<br \/>\nof FAS, CNI is entering into the non-competition and non-solicitation agreement<br \/>\nin the form attached hereto as Exhibit D (the &#8220;Non-Competition and<br \/>\nNon-Solicitation Agreement&#8221;) with Purchaser, which shall become effective as of<br \/>\nthe Closing.<\/p>\n<p>     F.   As a material inducement for Purchaser to purchase the capital stock<br \/>\nof FAS, Richard Ganley is entering into the consulting and non-competition<br \/>\nagreement in the form attached hereto as Exhibit E (the &#8220;Consulting Agreement&#8221;)<br \/>\nwith Purchaser, which will become effective as of the Closing.<\/p>\n<p>     G.   In connection with the Notes, the Purchaser will enter into a stock<br \/>\npledge agreement in the form attached hereto as Exhibit F (the &#8220;Pledge<br \/>\nAgreement&#8221;) at the Closing.<\/p>\n<p>     H.   As a material inducement for Purchaser to purchase the capital stock<br \/>\nof FAS, certain stockholders and employees of FAS are terminating existing<br \/>\nemployment and contingent payment obligations on the part of FAS.<\/p>\n<p>     I.   The parties hereto desire to make certain representations, warranties,<br \/>\ncovenants and other agreements in connection with the transactions contemplated<br \/>\nhereby.<\/p>\n<p>     NOW, THEREFORE, in consideration of the covenants, promises and<br \/>\nrepresentations set forth herein, and for other good and valuable consideration,<br \/>\nthe parties agree as follows:<\/p>\n<p>                                  ARTICLE 1.<\/p>\n<p>                      PURCHASE AND SALE OF THE SECURITIES<\/p>\n<p>     1.1 Purchase and Sale of the Securities. On the Closing Date and<br \/>\neffective as of the Closing (each as defined in Section 1.2 hereof), upon the<br \/>\nterms and subject to the conditions of this Agreement, the Shareholders shall<br \/>\nsell, convey, assign, transfer and deliver to the Purchaser, and the Purchaser<br \/>\nshall purchase from the Shareholders, the securities set forth opposite each<br \/>\nsuch shareholder&#8217;s name on Exhibit A hereto, in exchange for the total<br \/>\nconsideration, consisting of the Cash Payment, the Share Payment and the Notes<br \/>\n(the &#8220;Total Consideration&#8221;). The Total Consideration shall be payable by the<br \/>\nPurchaser to the Shareholders in accordance with the following:<\/p>\n<p>          (a)  Six million four hundred twelve thousand eight hundred thirty<br \/>\ndollars ($6,412,830.00) of the total consideration shall be payable in cash at<br \/>\nthe Closing (the &#8220;Cash Payment&#8221;);<\/p>\n<p>          (b)  Thirty three thousand and sixty two (33,062) shares of Common<br \/>\nStock of the Purchaser shall be delivered at Closing (the &#8220;Share Payment&#8221;); and<\/p>\n<p>          (c)  Six million nine hundred twenty two thousand nine hundred thirty<br \/>\ntwo dollars ($6,922,932) principal amount of the Notes shall be delivered at the<br \/>\nClosing and will be subject to Purchaser&#8217;s right of set off according to the<br \/>\nterms of Article 8 hereof.<\/p>\n<p>          (d)  The Cash Payment, the Share Payment and the Notes shall be<br \/>\nallocated among Shareholders in accordance with, and in the manner set forth on,<br \/>\nExhibit A hereto (such allocation being referred to herein as the &#8220;Allocation<br \/>\nPortion&#8221;).<\/p>\n<p>     1.2 Closing. Subject to the satisfaction or waiver of the conditions set<br \/>\nforth in Article 7 hereof, the consummation of the transactions contemplated<br \/>\nhereby pursuant to the terms and<\/p>\n<p>                                      -2-<\/p>\n<p>provisions hereof (the &#8220;Closing&#8221;) shall take place at the offices of Wilson<br \/>\nSonsini Goodrich &amp; Rosati, Professional Corporation, 650 Page Mill Road, Palo<br \/>\nAlto, California 94306, at 10:00 a.m. local California time, no later than the<br \/>\nsecond business day after satisfaction or waiver of the conditions set forth in<br \/>\nArticle 7 hereof, or at such other place, time and date as shall be mutually<br \/>\nagreed upon in writing by the parties hereto. The date upon which the Closing<br \/>\nshall actually occur shall be referred to herein as the &#8220;Closing Date.&#8221;<\/p>\n<p>     1.3  Closing Deliveries.<\/p>\n<p>               (a)  At the Closing, upon the terms and subject to the conditions<br \/>\nset forth herein, Shareholders shall jointly deliver each of the following:<\/p>\n<p>                         (i)    Certificates representing all of the outstanding<br \/>\ncapital stock of FAS (including all original instruments evidencing outstanding<br \/>\noptions, warrants or other rights to acquire capital stock of FAS);;<\/p>\n<p>                         (ii)   Duly and validly executed copies of the<br \/>\nEmployment and Non-Competition Agreements for each employee listed on Exhibit G<br \/>\nhereto;<\/p>\n<p>                         (iii)  A duly and validly executed copy of the Non-<br \/>\nCompetition and Non-Solicitation Agreement;<\/p>\n<p>                         (iv)   Duly and validly executed copies of the<br \/>\nemployment agreement termination and release described in Section 6.12 below for<br \/>\neach employee of HBF or its subsidiaries of FAS subject to an employment<br \/>\nagreement with HBF or any of its subsidiaries or FAS;<\/p>\n<p>                         (v)    Duly and validly executed copies of the<br \/>\ncontingent payment termination and release described in Section 6.14 below for<br \/>\neach individual or entity to which FAS has an existing obligation to make<br \/>\npayments based upon the financial performance of FAS;<\/p>\n<p>                         (vi)   A duly and validly executed copy of the Pledge<br \/>\nAgreement executed by each Shareholder;<\/p>\n<p>                         (vii)  Evidence of the First Refusal Release (as<br \/>\ndefined in Section 7.2(i) below); and<\/p>\n<p>                         (viii) A duly and validly executed copy of the<br \/>\nConsulting Agreement.<\/p>\n<p>               (b)  The Purchaser shall deliver:<\/p>\n<p>                         (i)    The Cash Payment payable by check or wire<br \/>\ntransfer to the accounts designated by the Shareholders; and<\/p>\n<p>                                      -3-<\/p>\n<p>                         (ii)   Stock certificates representing the Share<br \/>\nPayment, registered in the names designated by the Shareholders, which stock<br \/>\ncertificates shall carry the legend set forth in Section 6.1(a) hereof.<\/p>\n<p>                         (iii)  The Notes, in favor of the persons designated on<br \/>\nExhibit A hereto, subject to Purchaser&#8217;s right of set off in accordance with the<br \/>\nterms of Article 8;<\/p>\n<p>                         (iv)   A duly and validly executed copy of the Pledge<br \/>\nAgreement executed by the Purchaser; and<\/p>\n<p>                         (v)    Evidence of the Underwriter Consent (as defined<br \/>\nin Section 6.18 below);<\/p>\n<p>     1.4  Further Assurances. On and after the Closing, upon the reasonable<br \/>\nrequest of any of the other parties hereto, the parties hereto shall prepare,<br \/>\nexecute and deliver such other and further agreements, instruments,<br \/>\ncertificates, and other documents, and take, do and perform such other and<br \/>\nfurther actions, as may be necessary or appropriate in order to effectuate<br \/>\ncompletely the purposes and intent of this Agreement and to fully consummate the<br \/>\ntransactions contemplated hereby .<\/p>\n<p>                                  ARTICLE 2.<\/p>\n<p>          REPRESENTATIONS AND WARRANTIES OF FAS AND THE SHAREHOLDERS<\/p>\n<p>     As of the date hereof and as of the Closing Date, FAS and each of the<br \/>\nShareholders represents and warrants to Purchaser, subject to the exceptions<br \/>\nspecifically disclosed in writing in the disclosure letter and referencing a<br \/>\nspecific representation (unless it would be clearly apparent to a reasonable<br \/>\nperson that the disclosure would be relevant to another representation) supplied<br \/>\nby FAS and the Shareholders to Purchaser dated as of the date hereof and<br \/>\ncertified by a duly authorized officer of FAS and each of the Shareholders (the<br \/>\n&#8220;FAS Schedules&#8221;), as follows:<\/p>\n<p>     2.1  Organization of FAS.<\/p>\n<p>               (a)  Except as disclosed in Part 2.1(a) of the FAS Schedules, FAS<br \/>\nhas no subsidiaries and FAS owns no capital stock of, or any equity interest of<br \/>\nany nature in, any other entity. FAS has not agreed and is not obligated to<br \/>\nmake, nor bound by any written, oral or other agreement, contract, subcontract,<br \/>\nlease, binding understanding, instrument, note, option, warranty, purchase<br \/>\norder, license, sublicense, insurance policy, benefit plan or legally binding<br \/>\ncommitment or undertaking of any nature, as in effect as of the date hereof or<br \/>\nas may hereinafter be in effect (&#8220;Contract&#8221;) under which Contract it may become<br \/>\nobligated to make any future investment in or capital contribution to any other<br \/>\nentity. FAS has not, at any time, been a general partner of any general<br \/>\npartnership, limited<\/p>\n<p>                                      -4-<\/p>\n<p>partnership or other entity. When used herein, as applicable &#8220;FAS&#8221; refers to<br \/>\nFAS, its subsidiaries and predecessor entities.<\/p>\n<p>               (b)  FAS is a corporation duly organized, validly existing and in<br \/>\ngood standing under the laws of the jurisdiction of its incorporation and has<br \/>\nall necessary power and authority: (i) to conduct its business in the manner in<br \/>\nwhich its business is currently being conducted; (ii) to own and use its assets<br \/>\nin the manner in which its assets are currently owned and used; and (iii) to<br \/>\nperform its obligations under all Contracts by which it is bound.<\/p>\n<p>               (c)  FAS is qualified to do business as a foreign corporation,<br \/>\nand is in good standing, under the laws of all jurisdictions where the nature of<br \/>\nits business requires such qualification and where the failure to so qualify<br \/>\nwould have a Material Adverse Effect (as defined below) on FAS. With respect to<br \/>\nany entity, &#8220;Material Adverse Effect&#8221; shall mean any change, event or effect<br \/>\nthat is materially adverse to the consolidated business, assets (including<br \/>\nintangible assets), financial condition or results of operations of such entity.<\/p>\n<p>               (d)  FAS has delivered or made available to Purchaser a true and<br \/>\ncorrect copy of the Articles of Incorporation and Bylaws of FAS, each as amended<br \/>\nto date (collectively, the &#8220;FAS Charter Documents&#8221;), and each such instrument is<br \/>\nin full force and effect. FAS is not in violation of any of the provisions of<br \/>\nthe FAS Charter Documents.<\/p>\n<p>               (e)  There are no proposed or considered amendments to FAS<br \/>\nCharter Documents.<\/p>\n<p>     2.2  FAS Capital Structure.<\/p>\n<p>               (a)  The authorized capital stock of FAS consists of: 100,000<br \/>\nshares of FAS Common Stock, of which 2,000 shares are outstanding as of the date<br \/>\nof this Agreement. The FAS Common Stock, together with any other capital stock<br \/>\n(including any options, warrants or other rights to acquire FAS capital stock),<br \/>\nshall herein be referred to as the &#8220;FAS Capital Stock&#8221;. All of the outstanding<br \/>\nshares of FAS Capital Stock have been duly authorized and validly issued, and<br \/>\nare fully paid and nonassessable. As of the date of this Agreement, there are no<br \/>\nshares of FAS Capital Stock held in treasury by FAS. Part 2.2(a) of the FAS<br \/>\nSchedules contains a true, correct and complete list of the persons and entities<br \/>\nwho are record holders of any issued and outstanding shares of FAS Capital<br \/>\nStock, the respective number of shares, and the class or series, of FAS Capital<br \/>\nStock held by each such person or entity, as of the date hereof and as of the<br \/>\nClosing. There are no declared or accrued and unpaid dividends payable in<br \/>\nrespect of any shares of FAS Capital Stock.<\/p>\n<p>               (b)  All outstanding shares of FAS Capital Stock have been issued<br \/>\nand granted in compliance with (i) all applicable securities laws and other<br \/>\napplicable Legal Requirements (as defined below) and (ii) all requirements set<br \/>\nforth in applicable Contracts. For the purposes of this Agreement, &#8220;Legal<br \/>\nRequirements&#8221; means any federal, state, local, municipal, foreign or other law,<br \/>\nstatute, constitution, principle of common law, resolution, ordinance, code,<br \/>\nedict, decree, rule,<\/p>\n<p>                                     -5-<\/p>\n<p>regulation, ruling or requirement issued, enacted, adopted, promulgated,<br \/>\nimplemented or otherwise put into effect by or under the authority of any<br \/>\nGovernmental Entity (as defined below).<\/p>\n<p>     2.3  Obligations With Respect to Capital Stock . Except as set forth in<br \/>\nSection 2.2(a) hereof, there are no equity securities, partnership interests or<br \/>\nsimilar ownership interests of any class of any FAS equity security, or any<br \/>\nsecurities exchangeable or convertible into or exercisable for such equity<br \/>\nsecurities, partnership interests or similar ownership interests, issued,<br \/>\nreserved for issuance or outstanding. Except for securities FAS owns free and<br \/>\nclear of all claims and Encumbrances, as of the date of this Agreement, there<br \/>\nare no equity securities, partnership interests or similar ownership interests<br \/>\nof any class of equity security of any subsidiary of FAS, or any security<br \/>\nexchangeable or convertible into or exercisable for such equity securities,<br \/>\npartnership interests or similar ownership interests, issued, reserved for<br \/>\nissuance or outstanding. For the purposes of this Agreement, &#8220;Encumbrances&#8221;<br \/>\nmeans any lien, pledge, hypothecation, charge, mortgage, security interest,<br \/>\nencumbrance, claim, infringement, interference, option, trust, right of first<br \/>\nrefusal, preemptive right, community property interest or restriction of any<br \/>\nnature (including any restriction on the voting of any security, any restriction<br \/>\non the transfer of any security or other asset, any restriction on the receipt<br \/>\nof any income derived from any asset, any restriction on the use of any asset<br \/>\nand any restriction on the possession, exercise or transfer of any other<br \/>\nattribute of ownership of any asset). There are no subscriptions, options,<br \/>\nwarrants, equity securities, partnership interests or similar ownership<br \/>\ninterests, calls, rights (including preemptive rights), commitments or<br \/>\nagreements of any character to which FAS is a party or by which it is bound<br \/>\nobligating FAS to issue, deliver or sell, or cause to be issued, delivered or<br \/>\nsold, or repurchase, redeem or otherwise acquire, or cause the repurchase,<br \/>\nredemption or acquisition of, any shares of capital stock, partnership interests<br \/>\nor similar ownership interests of FAS or obligating FAS to grant, extend,<br \/>\naccelerate the vesting of or enter into any such subscription, option, warrant,<br \/>\nequity security, call, right, commitment or agreement. As of the date of this<br \/>\nAgreement, there are no registration rights and there is no voting trust, proxy,<br \/>\nrights plan, antitakeover plan or other agreement or understanding to which FAS<br \/>\nis a party or by which it is bound with respect to any equity security of any<br \/>\nclass of FAS.<\/p>\n<p>     2.4  Authority; Non-Contravention.<\/p>\n<p>               (a)  FAS has all requisite corporate power and authority to enter<br \/>\ninto this Agreement and to consummate the transactions contemplated hereby. The<br \/>\nexecution and delivery of this Agreement and the consummation of the<br \/>\ntransactions contemplated hereby have been duly authorized by all necessary<br \/>\ncorporate action on the part of FAS. This Agreement has been duly executed and<br \/>\ndelivered by FAS and, assuming due execution and delivery by the other parties<br \/>\nhereto, constitutes a valid and binding obligation of FAS, enforceable against<br \/>\nFAS in accordance with its terms, except as enforceability may be limited by<br \/>\nbankruptcy and other similar laws and general principles of equity. The<br \/>\nexecution and delivery of this Agreement by FAS does not, and the performance of<br \/>\nthis Agreement by FAS will not, (i) conflict with or violate the FAS Charter<br \/>\nDocuments, (ii) conflict with or violate any law, rule, regulation, order,<br \/>\njudgment or decree applicable to FAS or by which FAS or any of its respective<br \/>\nproperties is bound or affected, subject<\/p>\n<p>                                      -6-<\/p>\n<p>to compliance with the requirements set forth in Section 2.4(b) below or (iii)<br \/>\nresult in any material breach of or constitute a material default (or an event<br \/>\nthat with notice or lapse of time or both would become a material default)<br \/>\nunder, or impair FAS&#8217;s rights or alter the rights or obligations of any third<br \/>\nparty under, or give to others any rights of termination, amendment,<br \/>\nacceleration or cancellation of, or result in the creation of a material lien or<br \/>\nEncumbrance on any of the material properties or assets of FAS or any of its<br \/>\nsubsidiaries pursuant to, any material note, bond, mortgage, indenture,<br \/>\ncontract, agreement, lease, license, permit, franchise, concession, or other<br \/>\ninstrument or obligation to which FAS or any of its subsidiaries is a party or<br \/>\nby which FAS or any of its subsidiaries or its or any of their respective assets<br \/>\nare bound or affected. Part 2.4(a) of the FAS Schedules lists all consents,<br \/>\nwaivers and approvals under any of FAS&#8217;s or any of its subsidiaries&#8217; agreements,<br \/>\ncontracts, licenses or leases required to be obtained in connection with the<br \/>\nconsummation of the transactions contemplated hereby, which, if individually or<br \/>\nin the aggregate not obtained, would result in a material loss of benefits to<br \/>\nFAS or the Purchaser.<\/p>\n<p>               (b)  No consent, approval, order or authorization of, or<br \/>\nregistration, declaration or filing with any court, administrative agency or<br \/>\ncommission or other governmental authority or instrumentality, foreign or<br \/>\ndomestic (&#8220;Governmental Entity&#8221;), is required to be obtained or made by FAS in<br \/>\nconnection with the execution and delivery of this Agreement or the consummation<br \/>\nof the transactions contemplated by this Agreement, except for (i) such<br \/>\nconsents, approvals, orders, authorizations, registrations, declarations and<br \/>\nfilings as may be required under applicable federal, foreign and state<br \/>\nsecurities (or related) laws, the Hart-Scott-Rodino Antitrust Improvements Act<br \/>\nof 1976, as amended (the &#8220;HSR Act&#8221;) and the securities or antitrust laws of any<br \/>\nforeign country, and (ii) such other consents, authorizations, filings,<br \/>\napprovals and registrations which if not obtained or made would not be material<br \/>\nto Purchaser or FAS or have a material adverse effect on the ability of the<br \/>\nparties hereto to consummate the transactions contemplated hereby.<\/p>\n<p>     2.5  HBF Financial Statements. Part 2.5 of the FAS Schedules sets forth<br \/>\nunaudited balance sheet of The Homebuyer&#8217;s Fair, Inc., an Arizona corporation<br \/>\n(&#8220;HBF&#8221;), as of December 31, 1997 and the related unaudited statements of income<br \/>\nand cash flow for the 12 months ended December 31, 1997, and HBF&#8217;s unaudited<br \/>\nbalance sheet as of December 31, 1998 and the related unaudited statements of<br \/>\nincome and cash flow for the 12 months ended December 31, 1998 (collectively,<br \/>\nthe &#8220;Year End Financials&#8221;) (which Year End Financials include the results of<br \/>\nFAS), and (ii) HBF&#8217;s unaudited balance sheet as of June 27, 1999 (the &#8220;HBF<br \/>\nCurrent Balance Sheet&#8221;) and the related unaudited statements of income and cash<br \/>\nflow for the six (6) months then ended (collectively, the &#8220;HBF Current<br \/>\nFinancials&#8221;) (which Current Financials include the results of FAS). The Year End<br \/>\nFinancials and the HBF Current Financials shall collectively be referred to as<br \/>\nthe &#8220;HBF Financials.&#8221; The HBF Financials are correct in all material respects<br \/>\nand have been prepared in accordance with GAAP, applied on a basis consistent<br \/>\nthroughout the periods indicated and consistent with each other except as may be<br \/>\nindicated therein. The HBF Financials present fairly the financial condition,<br \/>\noperating results and cash flows of HBF as of the dates and during the periods<br \/>\nindicated therein, subject in the case of the HBF Current Financials, to normal<br \/>\nyear-end adjustments, which will not be material in amount or significance.<\/p>\n<p>                                      -7-<\/p>\n<p>     2.6  Absence of Certain Changes or Events. Since the date of the HBF<br \/>\nCurrent Balance Sheet there has not been: (i) any Material Adverse Effect on<br \/>\nFAS, (ii) any declaration, setting aside or payment of any dividend on, or other<br \/>\ndistribution (whether in cash, stock or property) in respect of, any of FAS<br \/>\nCapital Stock, or any purchase, redemption or other acquisition by FAS of any of<br \/>\nFAS&#8217;s Capital Stock or any options, warrants, calls or rights to acquire any<br \/>\nsuch shares or other securities, (iii) any split, combination or<br \/>\nreclassification of any FAS Capital Stock, (iv) any granting by FAS of any<br \/>\nincrease in compensation or fringe benefits, except for normal increases of cash<br \/>\ncompensation in the ordinary course of business consistent with past practice,<br \/>\nor any payment by FAS of any bonus, except for bonuses made in the ordinary<br \/>\ncourse of business consistent with past practice, or any granting by FAS of any<br \/>\nincrease in severance or termination pay or any entry by FAS into any currently<br \/>\neffective employment, severance, termination or indemnification agreement or any<br \/>\nagreement the benefits of which are contingent or the terms of which are<br \/>\nmaterially altered upon the occurrence of a transaction involving FAS of the<br \/>\nnature contemplated hereby, (v) entry by FAS into any licensing or other<br \/>\nagreement with regard to the acquisition or disposition of any material<br \/>\nIntellectual Property (as defined in Section 2.9) other than licenses in the<br \/>\nordinary course of business consistent with past practice, (vi) any material<br \/>\nchange by FAS in its accounting methods, principles or practices, except as<br \/>\nrequired by concurrent changes in GAAP or (vii) any revaluation by FAS of any of<br \/>\nits assets, including, without limitation, writing down the value of capitalized<br \/>\ninventory or writing off notes or accounts receivable other than in the ordinary<br \/>\ncourse of business and consistent with past practice.<\/p>\n<p>     2.7  Taxes.<\/p>\n<p>               (a)  Definition of Taxes. For the purposes of this Agreement,<br \/>\n&#8220;Tax&#8221; or &#8220;Taxes&#8221; refers to any and all federal, state, local and foreign taxes,<br \/>\nassessments and other governmental charges, duties, impositions and liabilities<br \/>\nrelating to taxes, including taxes based upon or measured by gross receipts,<br \/>\nincome, profits, sales, use and occupation, and value added, ad valorem,<br \/>\ntransfer, franchise, withholding, payroll, recapture, employment, excise and<br \/>\nproperty taxes, together with all interest, penalties and additions imposed with<br \/>\nrespect to such amounts and any obligations under any agreements or arrangements<br \/>\nwith any other person with respect to such amounts and including any liability<br \/>\nfor taxes of a predecessor entity.<\/p>\n<p>               (b)  Tax Returns and Audits.<\/p>\n<p>                         (i)    FAS has timely filed all federal, state, local<br \/>\nand foreign returns, estimates, information statements and reports (&#8220;Returns&#8221;)<br \/>\nrelating to Taxes required to be filed by FAS with any Tax authority. FAS has<br \/>\npaid all Taxes shown to be due on such Returns.<\/p>\n<p>                         (ii)   FAS as of the Closing will have withheld and<br \/>\nremitted on a timely basis to the appropriate authority all federal and state<br \/>\nincome taxes, Taxes pursuant to the Federal Insurance Contribution Act (&#8220;FICA&#8221;),<br \/>\nTaxes pursuant to the Federal Unemployment Tax Act (&#8220;FUTA&#8221;) and other Taxes<br \/>\nrequired to be withheld.<\/p>\n<p>                                      -8-<\/p>\n<p>                         (iii)  FAS has not been delinquent in the payment of<br \/>\nany Tax nor is there any material Tax deficiency outstanding, proposed or<br \/>\nassessed against FAS, nor has FAS executed any unexpired waiver of any statute<br \/>\nof limitations on or extending the period for the assessment or collection of<br \/>\nany material Tax.<\/p>\n<p>                         (iv)   No audit or other examination of any Return of<br \/>\nFAS by any Tax authority is presently in progress, nor has FAS been notified of<br \/>\nany request for such an audit or other examination.<\/p>\n<p>                         (v)    No adjustment relating to any Returns filed by<br \/>\nFAS has been proposed in writing formally or informally by any Tax authority to<br \/>\nFAS or any of its representatives.<\/p>\n<p>                         (vi)   FAS has no liability for unpaid Taxes which has<br \/>\nnot been accrued for or reserved on the HBF Current Balance Sheet, whether<br \/>\nasserted or unasserted, contingent or otherwise, which is material to FAS, other<br \/>\nthan any liability for unpaid Taxes that may have accrued since the date of the<br \/>\nHBF Current Balance Sheet in connection with the operation of the business of<br \/>\nFAS in the ordinary course.<\/p>\n<p>                         (vii)  There is no contract, agreement, plan or<br \/>\narrangement to which FAS is a party as of the date of this Agreement, including<br \/>\nbut not limited to the provisions of this Agreement, covering any employee or<br \/>\nformer employee of FAS (including leased employees from Novacare) that,<br \/>\nindividually or collectively, could give rise to the payment of any amount that<br \/>\nwould not be deductible pursuant to Sections 280G, 404 or 162(m) of the Code.<\/p>\n<p>                         (viii) FAS has not filed any consent agreement under<br \/>\nSection 341(f) of the Code or agreed to have Section 341(f)(2) of the Code apply<br \/>\nto any disposition of a subsection (f) asset (as defined in Section 341(f)(4) of<br \/>\nthe Code) owned by FAS.<\/p>\n<p>                         (ix)   FAS is not a party to or has any obligation<br \/>\nunder any tax-sharing, tax indemnity or tax allocation agreement or arrangement.<\/p>\n<p>                         (x)    Except as may be required as a result of this<br \/>\nAgreement, FAS has not been and will not be required to include any adjustment<br \/>\nin taxable income for any Tax period (or portion thereof) pursuant to Section<br \/>\n481 or Section 263A of the Code or any comparable provision under state or<br \/>\nforeign Tax laws as a result of transactions, events or accounting methods<br \/>\nemployed prior to the Closing.<\/p>\n<p>                         (xi)   None of FAS&#8217;s assets are tax-exempt use property<br \/>\nwithin the meaning of Section 168(h) of the Code.<\/p>\n<p>                         (xii)  Part 2.7 of the FAS Schedules lists (A) any<br \/>\nforeign Tax holidays, (B) any inter-company transfer pricing agreements, or<br \/>\nother arrangements that have been established by FAS with any Tax authority and<br \/>\n(C) any expatriate programs or policies affecting FAS.<\/p>\n<p>                                      -9-<\/p>\n<p>     2.8  Title to Properties; Absence of Liens and Encumbrances.<\/p>\n<p>               (a)  Part 2.8(a) of the FAS Schedules lists all real property<br \/>\nleases to which FAS is a party as of the date of this Agreement and each<br \/>\namendment thereto that is in effect as of the date of this Agreement. All such<br \/>\ncurrent leases are in full force and effect, are valid and effective in<br \/>\naccordance with their respective terms, and there is not, under any of such<br \/>\nleases, any existing default or event of default (or event which with notice or<br \/>\nlapse of time, or both, would constitute a default) that would give rise to a<br \/>\nmaterial claim. Other than the leaseholds created under the real property leases<br \/>\nidentified in Part 2.8(a) of the FAS Schedules, FAS owns no interest in real<br \/>\nproperty.<\/p>\n<p>               (b)  FAS has good and valid title to, or, in the case of leased<br \/>\nproperties and assets, valid leasehold interests in, all of its tangible<br \/>\nproperties and assets, real, personal and mixed, used or held for use in its<br \/>\nbusiness, free and clear of any liens, pledges, charges, claims, security<br \/>\ninterests or other encumbrances of any sort (&#8220;Liens&#8221;), except as reflected in<br \/>\nthe HBF Financials and except for liens for taxes not yet due and payable,<br \/>\nstatutory liens and such Liens or other imperfections of title and encumbrances,<br \/>\nif any, which are not material in character, amount or extent, and which do not<br \/>\nmaterially detract from the value, or materially interfere with the present use,<br \/>\nof the property subject thereto or affected thereby.<\/p>\n<p>     2.9  Intellectual Property. For the purposes of this Agreement, the<br \/>\nfollowing terms have the following definitions:<\/p>\n<p>               &#8220;Intellectual Property&#8221; shall mean any or all of the following<br \/>\n               and all rights in, arising out of, or associated therewith: (i)<br \/>\n               all United States, international and foreign patents and<br \/>\n               applications therefor and all reissues, divisions, renewals,<br \/>\n               extensions, provisionals, continuations and continuations-in-part<br \/>\n               thereof; (ii) all inventions (whether patentable or not),<br \/>\n               invention disclosures, improvements, trade secrets, proprietary<br \/>\n               information, know how, technology, technical data and customer<br \/>\n               lists, and all documentation relating to any of the foregoing;<br \/>\n               (iii) all copyrights, copyrights registrations and applications<br \/>\n               therefor, and all other rights corresponding thereto throughout<br \/>\n               the world; (iv) all industrial designs and any registrations and<br \/>\n               applications therefor throughout the world; (v) all trade names,<br \/>\n               logos, URLs, common law trademarks and service marks, trademark<br \/>\n               and service mark registrations and applications therefor<br \/>\n               throughout the world; (vi) all databases and data collections and<br \/>\n               all rights therein throughout the world; (vii) all moral and<br \/>\n               economic rights of authors and inventors, however denominated,<br \/>\n               throughout the world and (viii) any similar or equivalent rights<br \/>\n               to any of the foregoing anywhere in the world.<\/p>\n<p>               &#8220;FAS Intellectual Property&#8221; shall mean any Intellectual Property<br \/>\n               that is owned by, or exclusively licensed to, FAS.<\/p>\n<p>               &#8220;Registered Intellectual Property&#8221; means all United States,<br \/>\n               international and foreign: (i) patents and patent applications<br \/>\n               (including provisional applications); (ii)<\/p>\n<p>                                     -10-<\/p>\n<p>          registered trademarks, applications to register trademarks, intent-to-<br \/>\n          use applications, or other registrations or applications related to<br \/>\n          trademarks; (iii) registered copyrights and applications for copyright<br \/>\n          registration; and (iv) any other Intellectual Property that is the<br \/>\n          subject of an application, certificate, filing, registration or other<br \/>\n          document issued, filed with, or recorded by any state, government or<br \/>\n          other public legal authority.<\/p>\n<p>          &#8220;FAS Registered Intellectual Property&#8221; means all of the Registered<br \/>\n          Intellectual Property owned by, or filed in the name of, FAS.<\/p>\n<p>          (a) No material FAS Intellectual Property or product or service of FAS<br \/>\nis subject to any proceeding or outstanding decree, order, judgment, agreement<br \/>\nor stipulation restricting in any manner the use, transfer, or licensing thereof<br \/>\nby FAS, or which may affect the validity, use or enforceability of such FAS<br \/>\nIntellectual Property.<\/p>\n<p>          (b) Part 2.9(b) of the FAS Schedules is a complete and accurate list<br \/>\nof all FAS Registered Intellectual Property as of the date hereof and specifies,<br \/>\nwhere applicable, the jurisdictions in which each such item of FAS Registered<br \/>\nIntellectual Property has been issued or registered or in which an application<br \/>\nfor such issuance and registration has been filed, including the respective<br \/>\nregistration or application numbers. Each material item of FAS Registered<br \/>\nIntellectual Property is valid and subsisting, all necessary registration,<br \/>\nmaintenance and renewal fees currently due in connection with such Registered<br \/>\nIntellectual Property have been made and all necessary documents, recordations<br \/>\nand certificates currently due in connection with such Registered Intellectual<br \/>\nProperty have been filed with the relevant patent, copyright, trademark or other<br \/>\nauthorities in the United States or foreign jurisdictions, as the case may be,<br \/>\nfor the purposes of maintaining such Registered Intellectual Property.<\/p>\n<p>          (c) FAS owns and has good and exclusive title to, or has license<br \/>\n(sufficient for the conduct of its business as currently conducted and as<br \/>\ncurrently proposed to be conducted) to, each item of FAS Intellectual Property<br \/>\nor other material Intellectual Property used by FAS free and clear of any lien<br \/>\nor encumbrance (excluding licenses and related restrictions); and FAS is the<br \/>\nexclusive owner of all trademarks and trade names used in connection with the<br \/>\noperation or conduct of the business of FAS, including the sale of any products<br \/>\nor the provision of any services by FAS, within the scope of FAS &#8216;s use of such<br \/>\ntrademarks and trade names.<\/p>\n<p>          (d) FAS owns exclusively, and has good title to, all copyrighted works<br \/>\nthat are FAS products or which FAS otherwise expressly purports to own.<\/p>\n<p>          (e) To the extent that any material Intellectual Property has been<br \/>\ndeveloped or created by a third party for FAS, FAS has a written agreement with<br \/>\nsuch third party with respect thereto and FAS thereby either (i) has obtained<br \/>\nownership of, and is the exclusive owner of or (ii) has obtained a license<br \/>\n(sufficient for the conduct of its business as currently conducted and as<br \/>\ncurrently proposed to <\/p>\n<p>                                     -11-<\/p>\n<p>be conducted) to all such third party&#8217;s Intellectual Property in such work,<br \/>\nmaterial or invention by operation of law or by valid assignment, to the fullest<br \/>\nextent it is legally possible to do so.<\/p>\n<p>          (f) FAS has not transferred ownership of, or granted any exclusive<br \/>\nlicense with respect to, any Intellectual Property that is or was material to<br \/>\nFAS Intellectual Property, to any third party.<\/p>\n<p>          (g) The FAS Schedules list all material contracts, licenses and<br \/>\nagreements to which FAS is a party as of the date hereof (i) with respect to FAS<br \/>\nIntellectual Property licensed or transferred to any third party (other than<br \/>\nend-user licenses in the ordinary course); or (ii) pursuant to which a third<br \/>\nparty has licensed or transferred any material Intellectual Property to FAS.<\/p>\n<p>          All material contracts, licenses and agreements relating to FAS<br \/>\nIntellectual Property are in full force and effect.  The consummation of the<br \/>\ntransactions contemplated by this Agreement will neither violate nor result in<br \/>\nthe breach, modification, cancellation, termination or suspension of such<br \/>\ncontracts, licenses and agreements. FAS is in material compliance with, and has<br \/>\nnot materially breached any term any of such contracts, licenses and agreements<br \/>\nand, to the knowledge of FAS, all other parties to such contracts, licenses and<br \/>\nagreements are in compliance with, and have not materially breached any term of,<br \/>\nsuch contracts, licenses and agreements.  Following the Closing Date, the FAS<br \/>\nwill be permitted to exercise all of FAS&#8217;s rights under such contracts, licenses<br \/>\nand agreements to the same extent FAS would have been able to had the<br \/>\ntransactions contemplated by this Agreement not occurred and without the payment<br \/>\nof any additional amounts or consideration other than ongoing fees, royalties or<br \/>\npayments which FAS would otherwise be required to pay.<\/p>\n<p>          (h) The operation of the business of FAS, including FAS&#8217;s design,<br \/>\ndevelopment, manufacture, marketing and sale of the products or services of FAS<br \/>\n(including products and services currently under development) has not, does not<br \/>\nand will not infringe or misappropriate the Intellectual Property of any third<br \/>\nparty in any respect adverse to such party or constitute unfair competition or<br \/>\ntrade practices under the laws of any jurisdiction.<\/p>\n<p>          (i) FAS has not received notice from any third party that the<br \/>\noperation of the business of FAS or any act, product or service of FAS,<br \/>\ninfringes or misappropriates the Intellectual Property of any third party or<br \/>\nconstitutes unfair competition or trade practices under the laws of any<br \/>\njurisdiction.<\/p>\n<p>          (j) To the knowledge of FAS, no person has or is infringing or<br \/>\nmisappropriating, in any respect materially adverse to FAS, any FAS Intellectual<br \/>\nProperty.<\/p>\n<p>          (k) FAS has taken reasonable steps to protect FAS&#8217;s rights in FAS&#8217;s<br \/>\nconfidential information and trade secrets that it wishes to protect or any<br \/>\ntrade secrets or confidential information of third parties provided to FAS, and,<br \/>\nwithout limiting the foregoing, FAS has and enforces a policy requiring each<br \/>\nemployee (including leased employees from Novacare) and software and\/or web<br \/>\ndevelopment contractor (and the like) to execute a proprietary<br \/>\ninformation\/confidentiality agreement <\/p>\n<p>                                     -12-<\/p>\n<p>and all current employees (including leased employees from Novacare), software<br \/>\nand\/or web development contractors (and the like) of FAS have executed such an<br \/>\nagreement.<\/p>\n<p>     2.10 Compliance; Permits; Restrictions.  FAS is not in any material respect<br \/>\nin conflict with, or in default or in violation of (i) any law, rule,<br \/>\nregulation, order, judgment or decree applicable to FAS or by which FAS or any<br \/>\nof its respective properties is bound or affected or (ii) any material note,<br \/>\nbond, mortgage, indenture, contract, agreement, lease, license, permit,<br \/>\nfranchise or other instrument or obligation to which FAS is a party or by which<br \/>\nFAS or any of its respective properties is bound or affected, except for<br \/>\nconflicts, violations and defaults that (individually or in the aggregate) would<br \/>\nnot cause FAS to lose any material benefit or incur any material liability. To<br \/>\nFAS&#8217;s knowledge, no investigation or review by any Governmental Entity is<br \/>\npending or has been threatened against FAS, nor, to FAS&#8217;s knowledge, has any<br \/>\nGovernmental Entity indicated an intention to conduct an investigation of FAS.<br \/>\nThere is no material agreement, judgment, injunction, order or decree binding<br \/>\nupon FAS which has or would reasonably be expected to have the effect of<br \/>\nprohibiting or materially impairing any business practice of FAS or Purchaser,<br \/>\nany acquisition of material property by FAS or the conduct of business by FAS as<br \/>\ncurrently conducted.<\/p>\n<p>          (a) FAS holds, to the extent legally required, all permits, licenses,<br \/>\nvariances, exemptions, orders and approvals from Governmental Entities that are<br \/>\nmaterial to and required for the operation of the business of FAS as currently<br \/>\nconducted (collectively, the &#8220;FAS Permits&#8221;).  FAS is in compliance in all<br \/>\nmaterial respects with the terms of the FAS Permits, except where the failure to<br \/>\nbe in compliance with the terms of the FAS Permits would not be material to FAS<br \/>\nor Purchaser.<\/p>\n<p>          (b) There is no agreement (non-compete or otherwise), commitment,<br \/>\njudgment, injunction, order or decree to which FAS is a party or otherwise<br \/>\nbinding upon FAS which has, or may have the effect of, prohibiting or impairing<br \/>\nany business practice of FAS, any acquisition of property or assets (whether<br \/>\ntangible or intangible) by FAS, the conduct of business by FAS in any manner or<br \/>\notherwise limiting the freedom of FAS to engage in any line of business or<br \/>\ncompete with any person. FAS has not entered into any agreement, understanding<br \/>\nor other arrangement under which FAS is prohibited or restricted in any manner<br \/>\nfrom selling, licensing or otherwise distributing any technology or products to,<br \/>\nor providing services to, customers or potential customers or any class of<br \/>\ncustomers, in any geographic area, during any period of time or in any segment<br \/>\nof the market.<\/p>\n<p>     2.11 Litigation.  There are no claims, suits, actions or proceedings<br \/>\npending or, to the knowledge of FAS, threatened against, relating to or<br \/>\naffecting FAS, before any court, governmental department, commission, agency,<br \/>\ninstrumentality or authority, or any arbitrator that seeks to restrain or enjoin<br \/>\nthe consummation of the transactions contemplated by this Agreement or which<br \/>\nwould reasonably be expected, either singularly or in the aggregate with all<br \/>\nsuch claims, suits, actions or proceedings, to be material and adverse to FAS.<br \/>\nNo Governmental Entity has at any time challenged or questioned in a writing<br \/>\ndelivered to FAS the legal right of FAS to design, manufacture, offer or sell<br \/>\nany of its products or services in the present manner or style thereof. As of<br \/>\nthe date hereof, to <\/p>\n<p>                                     -13-<\/p>\n<p>the knowledge of FAS, no event has occurred, and no claim, dispute or other<br \/>\ncondition or circumstance exists, that will, or that would reasonably be<br \/>\nexpected to, cause or provide a bona fide basis for a director or executive<br \/>\nofficer of FAS to seek indemnification from FAS.<\/p>\n<p>     2.12 Brokers&#8217; and Finders&#8217; Fees.  FAS has not incurred, nor will it incur,<br \/>\ndirectly or indirectly, any liability for brokerage or finders&#8217; fees or agents&#8217;<br \/>\ncommissions or any similar charges in connection with this Agreement or any<br \/>\ntransaction contemplated hereby.<\/p>\n<p>     2.13 Interested Party Transactions.  No officer or director of FAS (nor, to<br \/>\nthe knowledge of FAS, any shareholder of FAS or any ancestor (up to once<br \/>\nremoved), sibling, descendant (up to once removed), spouse, parent, subsidiary<br \/>\nor other affiliate of any officer, director or shareholder, or any trust,<br \/>\npartnership or corporation in which any of such persons has or has had an<br \/>\ninterest), has or has had, directly or indirectly, (i) any material interest in<br \/>\nany entity that furnished or sold, or furnishes or sells, services, products or<br \/>\ntechnology that FAS furnishes or sells, or proposes to furnish or sell, (ii) any<br \/>\nmaterial interest in any entity that purchases from or sells or furnishes to FAS<br \/>\nany goods or services or (iii) a material beneficial interest in any Contract<br \/>\nother than employment or consulting agreements with officers of FAS and<br \/>\nindemnification agreements with directors and officers of FAS, in each case<br \/>\npreviously provided or made available to Purchaser; provided, however, that<br \/>\nownership of no more than one percent (1%) of the outstanding voting stock of a<br \/>\npublicly traded corporation and no more than percent (5%) of the outstanding<br \/>\nequity of any other entity shall not be deemed a material &#8220;interest in any<br \/>\nentity&#8221; for purposes of this Section 2.13.<\/p>\n<p>     2.14 Employee Benefit Plans.<\/p>\n<p>          (a) Definitions.  With the exception of the definition of &#8220;Affiliate&#8221;<br \/>\nset forth in Section 2.14(a)(i) below (which definition shall apply only to this<br \/>\nSection 2.14), for purposes of this Agreement, the following terms shall have<br \/>\nthe meanings set forth below:<\/p>\n<p>                    (i)    &#8220;Affiliate&#8221; shall mean any other person or entity<br \/>\nunder common control with FAS within the meaning of Section 414(b), (c), (m) or<br \/>\n(o) of the Code and the regulations issued thereunder;<\/p>\n<p>                    (ii)   &#8220;FAS Employee Plan&#8221; shall mean any plan, program,<br \/>\npolicy, practice, contract, agreement or other arrangement providing for<br \/>\ncompensation, severance, termination pay, performance awards, stock or stock-<br \/>\nrelated awards, fringe benefits or other employee benefits or remuneration of<br \/>\nany kind, whether written or unwritten or otherwise, funded or unfunded,<br \/>\nincluding without limitation, each &#8220;employee benefit plan,&#8221; within the meaning<br \/>\nof Section 3(3) of ERISA which is or has been maintained, contributed to, or<br \/>\nrequired to be contributed to, by FAS or any Affiliate for the benefit of any<br \/>\nEmployee;<\/p>\n<p>                    (iii)  &#8220;COBRA&#8221; shall mean the Consolidated Omnibus Budget<br \/>\nReconciliation Act of 1985, as amended;<\/p>\n<p>                                     -14-<\/p>\n<p>                    (iv)   &#8220;DOL&#8221; shall mean the United States Department of<br \/>\nLabor;<\/p>\n<p>                    (v)    &#8220;Employee&#8221; shall mean any current, former, or retired<br \/>\nemployee, officer, or director of FAS or any Affiliate (including any leased<br \/>\nemployee from Novacare);<\/p>\n<p>                    (vi)   &#8220;Employee Agreement&#8221; shall mean each management,<br \/>\nemployment, severance, consulting, relocation, repatriation, expatriation,<br \/>\nvisas, work permit or similar agreement or contract between FAS or any Affiliate<br \/>\nor Novacare and any Employee or consultant;<\/p>\n<p>                    (vii)  &#8220;ERISA&#8221; shall mean the Employee Retirement Income<br \/>\nSecurity Act of 1974, as amended;<\/p>\n<p>                    (viii) &#8220;FMLA&#8221; shall mean the Family Medical Leave Act of<br \/>\n1993, as amended;<\/p>\n<p>                    (ix)   &#8220;International Employee Plan&#8221; shall mean each FAS<br \/>\nEmployee Plan that has been adopted or maintained by FAS, whether informally or<br \/>\nformally, for the benefit of Employees outside the United States;<\/p>\n<p>                    (x)    &#8220;IRS&#8221; shall mean the Internal Revenue Service;<\/p>\n<p>                    (xi)   &#8220;Multiemployer Plan&#8221; shall mean any multiemployer<br \/>\nplan as defined in Section 4001(a)(3) of ERISA;<\/p>\n<p>                    (xii)  &#8220;PBGC&#8221; shall mean the Pension Benefit Guaranty<br \/>\nCorporation; and<\/p>\n<p>                    (xiii) &#8220;Pension Plan&#8221; shall mean each FAS Employee Plan<br \/>\nwhich is an &#8220;employee pension benefit plan,&#8221; within the meaning of Section 3(2)<br \/>\nof ERISA.<\/p>\n<p>          (b) Schedule.  Part 2.14(b) of the FAS Schedules contains an accurate<br \/>\nand complete list of each FAS Employee Plan and each Employee Agreement. FAS<br \/>\ndoes not have any plan or commitment to establish any new FAS Employee Plan, to<br \/>\nmodify any FAS Employee Plan or Employee Agreement (except to the extent<br \/>\nrequired by law or to conform any such FAS Employee Plan or Employee Agreement<br \/>\nto the requirements of any applicable law, in each case as previously disclosed<br \/>\nto Purchaser in writing, or as required by this Agreement), or to enter into any<br \/>\nFAS Employee Plan or Employee Agreement, nor does it have any intention or<br \/>\ncommitment to do any of the foregoing.<\/p>\n<p>          (c) Documents.  FAS has provided or, except in the case of clause (i)<br \/>\nbelow, made available through Novacare to Purchaser:  (i) correct and complete<br \/>\ncopies of all documents relating to each FAS Employee Plan and each Employee<br \/>\nAgreement including all amendments thereto and written interpretations thereof;<br \/>\n(ii) the most recent annual actuarial valuations, if any, prepared for each FAS<br \/>\nEmployee Plan; (iii) the three (3) most recent annual reports (Form Series 5500<br \/>\nand all <\/p>\n<p>                                     -15-<\/p>\n<p>schedules and financial statements attached thereto), if any, required under<br \/>\nERISA or the Code in connection with each FAS Employee Plan or related trust;<br \/>\n(iv) if FAS Employee Plan is funded, the most recent annual and periodic<br \/>\naccounting of FAS Employee Plan assets; (v) the most recent summary plan<br \/>\ndescription together with the summary of material modifications thereto, if any,<br \/>\nrequired under ERISA with respect to each FAS Employee Plan; (vi) all IRS<br \/>\ndetermination, opinion, notification and advisory letters, and rulings relating<br \/>\nto FAS Employee Plans and copies of all applications and correspondence to or<br \/>\nfrom the IRS or the DOL with respect to any FAS Employee Plan; (vii) all<br \/>\nmaterial written agreements and contracts relating to each FAS Employee Plan,<br \/>\nincluding, but not limited to, administrative service agreements, group annuity<br \/>\ncontracts and group insurance contracts; (viii) all communications material to<br \/>\nany Employee or Employees relating to any FAS Employee Plan and any proposed FAS<br \/>\nEmployee Plans, in each case, relating to any amendments, terminations,<br \/>\nestablishments, increases or decreases in benefits, acceleration of payments or<br \/>\nvesting schedules or other events which would result in any material liability<br \/>\nto FAS; (ix) all COBRA forms and related notices; and (x) all registration<br \/>\nstatements and prospectuses prepared in connection with each FAS Employee Plan.<\/p>\n<p>          (d) Employee Plan Compliance.  (i) FAS has performed in all material<br \/>\nrespects all obligations required to be performed by it under, is not in default<br \/>\nor violation of, and has no knowledge of any default or violation by any other<br \/>\nparty to each FAS Employee Plan, and each FAS Employee Plan has been established<br \/>\nand maintained in all material respects in accordance with its terms and in<br \/>\ncompliance with all applicable laws, statutes, orders, rules and regulations,<br \/>\nincluding but not limited to ERISA or the Code; (ii) to the knowledge of FAS,<br \/>\neach FAS Employee Plan intended to qualify under Section 401(a) of the Code and<br \/>\neach trust intended to qualify under Section 501(a) of the Code has either<br \/>\nreceived a favorable determination letter from the IRS with respect to each such<br \/>\nPlan as to its qualified status under the Code, including all amendments to the<br \/>\nCode effected by the Tax Reform Act of 1986 and subsequent legislation, or has<br \/>\nremaining a period of time under applicable Treasury regulations or IRS<br \/>\npronouncements in which to apply for such a determination letter and make any<br \/>\namendments necessary to obtain a favorable determination; (iii) to the knowledge<br \/>\nof FAS, no &#8220;prohibited transaction,&#8221; within the meaning of Section 4975 of the<br \/>\nCode or Sections 406 and 407 of ERISA, and not otherwise exempt under Section<br \/>\n408 of ERISA or 4975 of the Code, has occurred with respect to any FAS Employee<br \/>\nPlan; (iv) to the knowledge of FAS, there are no actions, suits or claims<br \/>\npending, threatened or reasonably anticipated (other than routine claims for<br \/>\nbenefits) against any FAS Employee Plan or against the assets of any FAS<br \/>\nEmployee Plan; (v) to the knowledge of FAS, each FAS Employee Plan can be<br \/>\namended, terminated or otherwise discontinued after the Closing Date in<br \/>\naccordance with its terms, without liability to Purchaser, FAS or any of its<br \/>\nAffiliates (other than ordinary administration expenses typically incurred in a<br \/>\ntermination event); (vi) to the knowledge of FAS, there are no audits, inquiries<br \/>\nor proceedings pending or threatened by the IRS or DOL with respect to any FAS<br \/>\nEmployee Plan; and (vii) to the knowledge of FAS, either FAS nor any Affiliate<br \/>\nis subject to any penalty or tax with respect to any FAS Employee Plan under<br \/>\nSection 402(i) of ERISA or Sections 4975 through 4980 of the Code.<\/p>\n<p>                                     -16-<\/p>\n<p>          (e) Pension Plans.  FAS does not now, nor has it ever, maintained,<br \/>\nestablished, sponsored, participated in, or contributed to, any Pension Plan<br \/>\nwhich is subject to Title IV of ERISA or Section 412 of the Code.<\/p>\n<p>          (f) Multiemployer Plans.  At no time has FAS contributed to or been<br \/>\nrequested to contribute to any Multiemployer Plan.<\/p>\n<p>          (g) No Post-Employment Obligations.  No FAS Employee Plan provides, or<br \/>\nhas any liability to provide, retiree life insurance, retiree health or other<br \/>\nretiree employee welfare benefits to any person for any reason, except as may be<br \/>\nrequired by COBRA or other applicable statute, and FAS has never represented,<br \/>\npromised or contracted (whether in oral or written form) to any Employee (either<br \/>\nindividually or to Employees as a group) or any other person that such<br \/>\nEmployee(s) or other person would be provided with retiree life insurance,<br \/>\nretiree health or other retiree employee welfare benefit, except to the extent<br \/>\nrequired by statute.<\/p>\n<p>          (h) To the knowledge of FAS, neither FAS nor any Affiliate has, prior<br \/>\nto the Closing, and in any material respect, violated any of the health care<br \/>\ncontinuation requirements of COBRA, the requirements of FMLA or any similar<br \/>\nprovisions of state law applicable to its Employees.<\/p>\n<p>          (i) Effect of Transaction.  The execution of this Agreement and the<br \/>\nconsummation of the transactions contemplated hereby will not (either alone or<br \/>\nupon the occurrence of any additional or subsequent events) constitute an event<br \/>\nunder any FAS Employee Plan or Employee Agreement that will or may result in any<br \/>\npayment (whether of severance pay or otherwise), acceleration, forgiveness of<br \/>\nindebtedness, vesting, distribution, increase in benefits or obligation to fund<br \/>\nbenefits with respect to any Employee.<\/p>\n<p>          (j) Employment Matters.  FAS:  (i) is in compliance in all material<br \/>\nrespects with all applicable foreign, federal, state and local laws, rules and<br \/>\nregulations respecting employment, employment practices, terms and conditions of<br \/>\nemployment and wages and hours, in each case, with respect to Employees; (ii)<br \/>\nhas withheld all amounts required by law or by agreement to be withheld from the<br \/>\nwages, salaries and other payments to Employees; (iii) is not liable for any<br \/>\narrears of wages or any taxes or any penalty for failure to comply with any of<br \/>\nthe foregoing; and (iv) is not liable for any material payment to any trust or<br \/>\nother fund or to any governmental or administrative authority, with respect to<br \/>\nunemployment compensation benefits, social security or other benefits or<br \/>\nobligations for Employees (other than routine payments to be made in the normal<br \/>\ncourse of business and consistent with past practice).  There are no pending,<br \/>\nthreatened or reasonably anticipated claims or actions against FAS under any<br \/>\nworker&#8217;s compensation policy or long-term disability policy.  To FAS&#8217;s<br \/>\nknowledge, no employee of FAS has violated any employment contract,<br \/>\nnondisclosure agreement or noncompetition agreement by which such employee is<br \/>\nbound due to such employee being employed by FAS and disclosing to FAS or using<br \/>\ntrade secrets or proprietary information of any other person or entity.<\/p>\n<p>                                     -17-<\/p>\n<p>          (k) Labor.  To the knowledge of FAS, no work stoppage or labor strike<br \/>\nagainst FAS is pending, threatened or reasonably anticipated.  FAS has no<br \/>\nknowledge of any activities or proceedings of any labor union to organize any<br \/>\nEmployees. To the knowledge of FAS, there are no actions, suits, claims, labor<br \/>\ndisputes or grievances pending, threatened or reasonably anticipated relating to<br \/>\nany labor, safety or discrimination matters involving any Employee, including,<br \/>\nwithout limitation, charges of unfair labor practices or discrimination<br \/>\ncomplaints, which, if adversely determined, would, individually or in the<br \/>\naggregate, result in any material liability to FAS.  FAS has not engaged in any<br \/>\nunfair labor practices within the meaning of the National Labor Relations Act.<br \/>\nFAS is not presently, nor has it been in the past, a party to, or bound by, any<br \/>\ncollective bargaining agreement or union contract with respect to Employees and<br \/>\nno collective bargaining agreement is being negotiated by FAS.<\/p>\n<p>          (l) International Employee Plan.  FAS does not now, nor has it ever<br \/>\nhad the obligation to, maintain, establish, sponsor, participate in, or<br \/>\ncontribute to any International Employee Plan.<\/p>\n<p>     2.15 Environmental Matters.<\/p>\n<p>          (a) Hazardous Material.  Except as would not result in material<br \/>\nliability to FAS, no underground storage tanks and no amount of any substance<br \/>\nthat has been designated by any Governmental Entity or by applicable federal,<br \/>\nstate or local law to be radioactive, toxic, hazardous or otherwise a danger to<br \/>\nhealth or the environment, including, without limitation, PCBs, asbestos,<br \/>\npetroleum, urea-formaldehyde and all substances listed as hazardous substances<br \/>\npursuant to the Comprehensive Environmental Response, Compensation, and<br \/>\nLiability Act of 1980, as amended, or defined as a hazardous waste pursuant to<br \/>\nthe United States Resource Conservation and Recovery Act of 1976, as amended,<br \/>\nand the regulations promulgated pursuant to said laws, but excluding office and<br \/>\njanitorial supplies (a &#8220;Hazardous Material&#8221;) are present, as a result of the<br \/>\nactions of FAS or any affiliate of FAS, or, to FAS&#8217;s knowledge, as a result of<br \/>\nany actions of any third party or otherwise, in, on or under any property,<br \/>\nincluding the land and the improvements, ground water and surface water thereof,<br \/>\nthat FAS or any of its subsidiaries has at any time owned, operated, occupied or<br \/>\nleased.<\/p>\n<p>          (b) Hazardous Materials Activities.  Except as would not result in a<br \/>\nmaterial liability to FAS (in any individual case or in the aggregate) (i) FAS<br \/>\nhas not transported, stored, used, manufactured, disposed of, released or<br \/>\nexposed its employees or others to Hazardous Materials in violation of any law<br \/>\nin effect on or before the Closing Date and (ii) FAS has not disposed of,<br \/>\ntransported, sold, used, released, exposed its employees or others to or<br \/>\nmanufactured any product containing a Hazardous Material (collectively<br \/>\n&#8220;Hazardous Materials Activities&#8221;) in violation of any rule, regulation, treaty<br \/>\nor statute promulgated by any Governmental Entity in effect prior to or as of<br \/>\nthe date hereof to prohibit, regulate or control Hazardous Materials or any<br \/>\nHazardous Material Activity.<\/p>\n<p>                                     -18-<\/p>\n<p>          (c) Permits.  FAS holds all environmental approvals, permits,<br \/>\nlicenses, clearances and consents (the &#8220;FAS Environmental Permits&#8221;) necessary<br \/>\nfor the conduct of FAS&#8217;s and its subsidiaries&#8217; Hazardous Material Activities and<br \/>\nother businesses of FAS and its subsidiaries as such activities and businesses<br \/>\nare currently being conducted.<\/p>\n<p>          (d) Environmental Liabilities.  No action, proceeding, revocation<br \/>\nproceeding, amendment procedure, writ or injunction is pending, and to the<br \/>\nknowledge of FAS, no action, proceeding, revocation proceeding, amendment<br \/>\nprocedure, writ or injunction has been threatened by any Governmental Entity<br \/>\nagainst FAS or any of its subsidiaries in a writing delivered to FAS concerning<br \/>\nany FAS Environmental Permit, Hazardous Material or any Hazardous Materials<br \/>\nActivity of FAS.  FAS has no knowledge of any fact or circumstance which would<br \/>\ninvolve FAS in any environmental litigation or impose upon FAS any material<br \/>\nenvironmental liability.<\/p>\n<p>     2.16 Year 2000 Compliance.  FAS&#8217;s products and internal systems have been<br \/>\ndesigned to ensure date and time entry recognition, calculations that<br \/>\naccommodate same century and multi-century formulas and date values, leap year<br \/>\nrecognition and calculations, and date data interface values that accurately<br \/>\nreflect the century. FAS&#8217;s products and internal systems manage and manipulate<br \/>\ndata involving dates and times, including single century formulas and multi-<br \/>\ncentury formulas, and do not cause an abnormal ending scenario within the<br \/>\napplication or generate incorrect values or invalid results involving such<br \/>\ndates.<\/p>\n<p>     2.17 Agreements, Contracts and Commitments.  Except as otherwise set forth<br \/>\nin Part 2.17 of the FAS Schedules, as of the date hereof FAS is not a party to<br \/>\nor bound by:<\/p>\n<p>          (a) any employment or consulting agreement, contract or commitment<br \/>\ncurrently in force with any employee, officer or member of FAS&#8217;s Board of<br \/>\nDirectors, other than those that are terminable by FAS or any of its<br \/>\nsubsidiaries on no more than thirty (30) days&#8217; notice without liability or<br \/>\nfinancial obligation, except to the extent general principles of wrongful<br \/>\ntermination law may limit FAS&#8217;s ability to terminate employees at will;<\/p>\n<p>          (b) any agreement of indemnification or any guaranty by FAS currently<br \/>\nin force other than any agreement of indemnification entered into in connection<br \/>\nwith the sale or license of software products in the ordinary course of<br \/>\nbusiness;<\/p>\n<p>          (c) any agreement, contract or commitment containing any covenant<br \/>\ncurrently in force limiting in any respect the right of FAS to engage in any<br \/>\nline of business or to compete with any person or granting any exclusive<br \/>\ndistribution rights;<\/p>\n<p>          (d) any agreement, contract or commitment currently in force relating<br \/>\nto the disposition or acquisition by FAS after the date of this Agreement of a<br \/>\nmaterial amount of assets not in the ordinary course of business or pursuant to<br \/>\nwhich FAS has any material ownership interest in any corporation, partnership,<br \/>\njoint venture or other business enterprise other than FAS&#8217;s subsidiaries;<\/p>\n<p>                                     -19-<\/p>\n<p>          (e) any joint marketing or development agreement currently in force<br \/>\nunder which FAS or any of its subsidiaries have continuing material obligations<br \/>\nto jointly market any product, technology or service and which may not be<br \/>\ncanceled without penalty upon notice of ninety (90) days or less, or any<br \/>\nmaterial agreement pursuant to which FAS has continuing material obligations to<br \/>\njointly develop any intellectual property that will not be owned, in whole or in<br \/>\npart, by FAS and which may not be canceled without penalty upon notice of ninety<br \/>\n(90) days or less;<\/p>\n<p>          (f) any agreement, contract or commitment currently in force to<br \/>\nprovide source code to any third party for any product or technology that is<br \/>\nmaterial to FAS;<\/p>\n<p>          (g) any agreement or plan currently in force, including, without<br \/>\nlimitation, any stock option plan, stock appreciation right plan or stock<br \/>\npurchase plan, any of the benefits of which will be increased, or the vesting of<br \/>\nbenefits of which will be accelerated, by the occurrence of any of the<br \/>\ntransactions contemplated by this Agreement or the value of any of the benefits<br \/>\nof which will be calculated on the basis of any of the transactions contemplated<br \/>\nby this Agreement;<\/p>\n<p>          (h) any agreement, contract or commitment currently in force to sell<br \/>\nor distribute any FAS products, service or technology except agreements with<br \/>\ndistributors or sales representatives in the normal course of business<br \/>\ncancelable without penalty upon notice of ninety (90) days or less and<br \/>\nsubstantially in the form previously provided or made available to Purchaser;<\/p>\n<p>          (i) any mortgages, indentures, guarantees, loans or credit agreements,<br \/>\nsecurity agreements or other agreements or instruments currently in force<br \/>\nrelating to the borrowing of money or extension of credit;<\/p>\n<p>          (j) any settlement agreement entered into within two (2) years prior<br \/>\nto the date of this Agreement; or<\/p>\n<p>          (k) any other agreement, contract or commitment that has a value of<br \/>\n$50,000 or more individually.<\/p>\n<p>     Neither FAS, nor to FAS&#8217;s knowledge any other party to a material Contract,<br \/>\nis in breach, violation or default under, and FAS has not received written<br \/>\nnotice that it has breached, violated or defaulted under, any of the material<br \/>\nterms or conditions of any material Contract to which FAS is bound, in such a<br \/>\nmanner as would permit any other party to cancel or terminate any such material<br \/>\nContract, or would permit any other party to seek material damages or other<br \/>\nremedies (for any or all of such breaches, violations or defaults, in the<br \/>\naggregate).<\/p>\n<p>     2.18 Insurance.  FAS maintains insurance policies and fidelity bonds<br \/>\ncovering the assets, business, equipment, properties, operations, employees,<br \/>\nofficers and directors of FAS (collectively, the &#8220;Insurance Policies&#8221;) which are<br \/>\nset forth on Part 2.18 of the FAS Schedules. There is no material claim by FAS<br \/>\npending under any of the material Insurance Policies as to which coverage has<br \/>\nbeen questioned, denied or disputed by the underwriters of such policies or<br \/>\nbonds.<\/p>\n<p>                                     -20-<\/p>\n<p>     2.19   Contingent Payment Arrangements. Following the Closing, neither<br \/>\nPurchaser nor FAS will have any obligation to make any payments to any<br \/>\nindividual or entity based upon the financial performance of FAS.<\/p>\n<p>                                  ARTICLE 3.<\/p>\n<p>              REPRESENTATIONS AND WARRANTIES OF EACH SHAREHOLDER<\/p>\n<p>     As of the date hereof and as of the Closing Date, each of the Shareholders<br \/>\nfurther represents and warrants to Purchaser, as follows:<\/p>\n<p>     3.1 Ownership of Shares. As of the date hereof, such Shareholder is the<br \/>\nsole record and beneficial owner of the shares of FAS Capital Stock designated<br \/>\nas being owned by such Shareholder opposite such Shareholder&#8217;s name in Part<br \/>\n2.2(a) of the FAS Schedules. As of the Closing, such Shareholder will be the<br \/>\nsole record and beneficial owner of the shares of FAS Capital Stock designated<br \/>\nas being owned by such Shareholder opposite such Shareholder&#8217;s name in Part<br \/>\n2.2(a) of the FAS Schedules. Such shares are not subject to any Encumbrances and<br \/>\nwill not become subject to any Encumbrances upon transfer to the Purchaser, and<br \/>\nsuch Shareholder has not granted any rights to purchase such shares to any other<br \/>\nperson or entity. Such Shareholder has the sole right to transfer such shares to<br \/>\nPurchaser. Such shares constitute all of the FAS Capital Stock owned by such<br \/>\nShareholder, and such Shareholder has no options, warrants or other rights to<br \/>\nacquire FAS Capital Stock. Upon the Closing, Purchaser will receive good title<br \/>\nto such shares, subject to no Encumbrances retained, granted or permitted by<br \/>\nsuch stockholder or FAS. Such Shareholder has not engaged in any sale or other<br \/>\ntransfer of any FAS Capital Stock in contemplation of the transactions<br \/>\ncontemplated by this Agreement.<\/p>\n<p>     3.2 Authority; Non-Contravention.<\/p>\n<p>               (a)  Such Shareholder has all requisite power and authority to<br \/>\nenter into this Agreement and to consummate the transactions contemplated<br \/>\nhereby. The execution and delivery of this Agreement and the consummation of the<br \/>\ntransactions contemplated hereby have been duly authorized by all necessary<br \/>\naction on the part of such Shareholder. This Agreement has been duly executed<br \/>\nand delivered by such Shareholder and, assuming due execution and delivery by<br \/>\nother parties hereto, constitutes a valid and binding obligation of such<br \/>\nShareholder, enforceable against such Shareholder in accordance with its terms,<br \/>\nexcept as enforceability may be limited by bankruptcy and other similar laws and<br \/>\ngeneral principles of equity. The execution and delivery of this Agreement by<br \/>\nsuch Shareholder does not, and the performance of this Agreement by such<br \/>\nShareholder will not, (i) if applicable, conflict with the organizational<br \/>\ndocuments of such Shareholder, (ii) conflict with or violate any law, rule,<br \/>\nregulation, order, judgment or decree applicable to such Shareholder or by which<br \/>\nShareholder or, if applicable, any of its respective properties is bound or<br \/>\naffected, subject to compliance with the requirements set forth in Section<br \/>\n3.2(b) below<\/p>\n<p>                                     -21-<\/p>\n<p>          (b)  No consent, approval, order or authorization of, or registration,<br \/>\ndeclaration or filing with any Governmental Entity, is required to be obtained<br \/>\nor made by such Shareholder in connection with the execution and delivery of<br \/>\nthis Agreement or the consummation of the transactions contemplated hereby,<br \/>\nexcept for (i) such consents, approvals, orders, authorizations, registrations,<br \/>\ndeclarations and filings as may be required under applicable federal, foreign<br \/>\nand state securities (or related) laws, the HSR Act and the securities or<br \/>\nantitrust laws of any foreign country, and (ii) such other consents,<br \/>\nauthorizations, filings, approvals and registrations which if not obtained or<br \/>\nmade would not be material to Purchaser or FAS or have a material adverse effect<br \/>\non the ability of the parties hereto to consummate the transactions contemplated<br \/>\nby the Agreement.<\/p>\n<p>  3.3  Investment Representations.<\/p>\n<p>          (a)  Shareholder is aware of the Purchaser&#8217;s business affairs and<br \/>\nfinancial condition and has acquired sufficient information about the Purchaser<br \/>\nto reach an informed and knowledgeable decision to acquire the securities.<br \/>\nShareholder is purchasing such Shareholder&#8217;s allocation of the Share Payment for<br \/>\ninvestment for his own account only and not with a view to, or for resale in<br \/>\nconnection with, any &#8220;distribution&#8221; thereof within the meaning of the Securities<br \/>\nAct of 1933, as amended (the &#8220;Securities Act&#8221;).<\/p>\n<p>          (b)  Shareholder understands that the shares constituting the Share<br \/>\nPayment have not been registered under the Securities Act by reason of a<br \/>\nspecific exemption therefrom, which exemption depends upon, among other things,<br \/>\nthe bona fide nature of his investment intent and other representations as<br \/>\nexpressed herein.<\/p>\n<p>          (c)  Shareholder further acknowledges and understands that the<br \/>\nShareholder&#8217;s portion of the shares constituting the Share Payment must be held<br \/>\nindefinitely unless they are subsequently registered under the Securities Act or<br \/>\nan exemption from such registration is available. Shareholder understands that<br \/>\nthe certificate evidencing such Shareholder&#8217;s portion of the Share Payment will<br \/>\nbe imprinted with a legend which prohibits the transfer of the securities unless<br \/>\nthey are registered or such registration is not required in the opinion of<br \/>\ncounsel for the Purchaser. Shareholder further acknowledges that the Purchaser<br \/>\nis under no obligation to register the shares constituting the Share Payment.<\/p>\n<p>          (d)  Shareholder is an accredited investor as defined in Rule 501(a)<br \/>\nof Regulation D promulgated under the Securities Act or Shareholder, by reason<br \/>\nof Shareholder&#8217;s business or financial experience has the capacity to protect<br \/>\nShareholder&#8217;s own interests in connection with the receipt of the shares<br \/>\nconstituting the Share Payment.<\/p>\n<p>          (e)  Shareholder is aware of the adoption of Rule 144 by the<br \/>\nSecurities and Exchange Commission (the &#8220;SEC&#8221;), promulgated under the Securities<br \/>\nAct, which permits limited public resale of securities acquired in a non-public<br \/>\noffering subject to the satisfaction of certain conditions set forth therein,<br \/>\nincluding, among other things, a one-year holding period, the availability of<br \/>\ncertain public information about the issuer, the requirement that the sale be<br \/>\neffect through a &#8220;broker&#8217;s<\/p>\n<p>                                     -22-<\/p>\n<p>transaction&#8221; or in transactions directly with a &#8220;market maker&#8221; (as defined in<br \/>\nRule 144) and the number of shares being sold in any three-month period not<br \/>\nexceeding specific limitations.<\/p>\n<p>          (f)  Shareholder further acknowledges that in the event all of the<br \/>\nrequirements of Rule 144 are not met, some other registration exemption will be<br \/>\nrequired; and that although Rule 144 is not exclusive, the staff of the SEC has<br \/>\nexpressed its opinion that persons proposing to sell private placement<br \/>\nsecurities other than in a registered offering and other than pursuant to Rule<br \/>\n144 will have a substantial burden of proof in establishing that an exemption<br \/>\nfrom registration is available for such offers or sales and that such persons<br \/>\nand the brokers who participate in the transactions do so at their own risk.<\/p>\n<p>          (g)  The Shareholder understands that Shareholder (and not the<br \/>\nPurchaser) shall be responsible for his own federal, state, local or foreign tax<br \/>\nliability and any of his other tax consequences that may arise as a result of<br \/>\nthe transactions contemplated by this Agreement. Shareholder shall rely solely<br \/>\non the determinations of his tax advisors or his own determinations, and not on<br \/>\nany statements or representations by the Purchaser or any of its agents, with<br \/>\nregard to all such tax matters.<\/p>\n<p>          (h)  Shareholder understands that the transfer of the Shares has not<br \/>\nbeen qualified with the Commissioner of Corporations of the State of California<br \/>\nand the issuance of such securities or the payment or receipt of any part of the<br \/>\nconsideration therefor prior to such qualification is unlawful unless the sale<br \/>\nof securities is exempt from qualification by the California Corporations Code.<\/p>\n<p>                                  ARTICLE 4.<\/p>\n<p>                  REPRESENTATIONS AND WARRANTIES OF PURCHASER<\/p>\n<p>     As of the date hereof and as of the Closing Date, Purchaser represents and<br \/>\nwarrants to each Shareholder, subject to the exceptions specifically disclosed<br \/>\nin writing in the disclosure letter and referencing a specific representation<br \/>\n(unless it would be clearly apparent to a reasonable person that the disclosure<br \/>\nwould be relevant to another representation) supplied by Purchaser to each of<br \/>\nthe Shareholders dated as of the date hereof and certified by a duly authorized<br \/>\nofficer of Purchaser (the &#8220;Purchaser Schedules&#8221;), as follows:<\/p>\n<p>  4.1  Authority; Non-Contravention.<\/p>\n<p>          (a)  Purchaser has all requisite corporate power and authority to<br \/>\nenter into this Agreement and to consummate the transactions contemplated<br \/>\nhereby. The execution and delivery of this Agreement and the consummation of the<br \/>\ntransactions contemplated hereby have been duly authorized by all necessary<br \/>\ncorporate action on the part of Purchaser. This Agreement has been duly executed<br \/>\nand delivered by Purchaser and assuming execution and delivery by the other<br \/>\nparties hereto constitutes a valid and binding obligation of Purchaser,<br \/>\nenforceable against Purchaser in accordance with its terms, except as<br \/>\nenforceability may be limited by bankruptcy and other similar laws and<\/p>\n<p>                                     -23-<\/p>\n<p>general principles of equity. The execution and delivery of this Agreement by<br \/>\nPurchaser does not, and the performance of this Agreement by Purchaser will not,<br \/>\n(i) conflict with the Purchaser Charter Documents (as defined below), (ii)<br \/>\nconflict with or violate any law, rule, regulation, order, judgment or decree<br \/>\napplicable to Purchaser or any of its subsidiaries or by which Purchaser or any<br \/>\nof its subsidiaries or any of their respective properties are bound or affected,<br \/>\nsubject to compliance with the requirements set forth in Section 4.1(b) below or<br \/>\n(iii) result in any breach of or constitute a default (or an event that with<br \/>\nnotice or lapse of time or both would become a material default) under, or<br \/>\nimpair Purchaser&#8217;s rights or alter the rights or obligations of any third party<br \/>\nunder, or give to others any rights of termination, amendment, acceleration or<br \/>\ncancellation of, or result in the creation of lien or Encumbrance on any of the<br \/>\nproperties or assets of Purchaser or any of its subsidiaries pursuant to, any<br \/>\nnote, bond, mortgage, indenture, contract, agreement, lease, license, permit,<br \/>\nfranchise, concession, or other instrument or obligation to which Purchaser or<br \/>\nany of its subsidiaries is a party or by which Purchaser or any of its<br \/>\nsubsidiaries or its or any of their respective assets are bound or affected, any<br \/>\nof which would result in a Material Adverse Effect on Purchaser. Part 4.1(a) of<br \/>\nthe Purchaser Schedules lists all consents, waivers and approvals under any of<br \/>\nPurchaser&#8217;s or any of its subsidiaries&#8217; agreements, contracts, licenses or<br \/>\nleases required to be obtained in connection with the consummation of the<br \/>\ntransactions contemplated hereby, which, if individually or in the aggregate not<br \/>\nobtained, would result in a material loss of benefits to the Purchaser.<\/p>\n<p>          (b)  No consent, approval, order or authorization of, or registration,<br \/>\ndeclaration or filing with any Governmental Entity, is required to be obtained<br \/>\nor made by Purchaser or any of its subsidiaries in connection with the execution<br \/>\nand delivery of this Agreement or the consummation of the transactions<br \/>\ncontemplated by this Agreement, except for (i) such consents, approvals, orders,<br \/>\nauthorizations, registrations, declarations and filings as may be required under<br \/>\napplicable federal, foreign and state securities (or related) laws, the HSR Act<br \/>\nand the securities or antitrust laws of any foreign country and (ii) such other<br \/>\nconsents, authorizations, filings, approvals and registrations which if not<br \/>\nobtained or made would not be material to Purchaser or have a material adverse<br \/>\neffect on the ability of the parties hereto to consummate the transactions<br \/>\ncontemplated by this Agreement.<\/p>\n<p>     4.2 Organization of Purchaser.<\/p>\n<p>          (a)  Purchaser is a corporation duly organized, validly existing and<br \/>\nin good standing under the laws of the jurisdiction of its incorporation and has<br \/>\nall necessary power and authority: (i) to conduct its business in the manner in<br \/>\nwhich its business is currently being conducted; (ii) to own and use its assets<br \/>\nin the manner in which its assets are currently owned and used; and (iii) to<br \/>\nperform its obligations under all material Contracts by which it is bound.<\/p>\n<p>          (b)  Purchaser is qualified to do business as a foreign corporation,<br \/>\nand is in good standing, under the laws of all jurisdictions where the nature of<br \/>\nits business requires such qualification and where the failure to so qualify<br \/>\nwould have a Material Adverse Effect on Purchaser.<\/p>\n<p>          (c)  Purchaser has delivered or made available to FAS a true and<br \/>\ncorrect copy of the Certificate of Incorporation and Bylaws of Purchaser, each<br \/>\nas amended to date (collectively, the<\/p>\n<p>                                     -24-<\/p>\n<p>&#8220;Purchaser Charter Documents&#8221;), and each such instrument is in full force and<br \/>\neffect. Purchaser is not in violation of any of the provisions of the Purchaser<br \/>\nCharter Documents.<\/p>\n<p>     4.3 Purchaser SEC Filings; Financial Statements.<\/p>\n<p>          (a)  Purchaser has filed all forms, reports and document required to<br \/>\nbe filed with the SEC since August 4, 1999. All such required forms, reports and<br \/>\ndocuments (including those that Purchaser may file subsequent to the date<br \/>\nhereof) are referred to herein as the &#8220;Purchaser SEC Reports&#8221;). As of their<br \/>\nrespective dates (or, if amended, as of the respective dates of such<br \/>\namendments), Purchaser SEC Reports (i) complied as to form in all material<br \/>\nrespects with the requirements of the Securities Act, or the Exchange Act of<br \/>\n1934, as amended (the &#8220;Exchange Act&#8221;), as the case may be, and the rules and<br \/>\nregulations of the SEC thereunder applicable to such Purchaser SEC Reports and<br \/>\n(ii) did not at the time they were filed contain any untrue statement of a<br \/>\nmaterial fact or omit to state a material fact required to be stated therein or<br \/>\nnecessary in order to make the statements therein, in the light of the<br \/>\ncircumstances under which they were made, not misleading. None of Purchaser&#8217;s<br \/>\nsubsidiaries is required to file any forms, reports or other documents with the<br \/>\nSEC.<\/p>\n<p>          (b)  Each of the consolidated financial statements (including, in each<br \/>\ncase, any related notes thereto) contained in Purchaser SEC Reports (the<br \/>\n&#8220;Purchaser Financials&#8221;) (i) complied as to form in all material respects with<br \/>\nthe published rules and regulations of the SEC with respect thereto, (ii) was<br \/>\nprepared in accordance with GAAP applied on a consistent basis throughout the<br \/>\nperiods involved (except as may be indicated in the notes thereto or, in the<br \/>\ncase of unaudited interim financial statements, as may be permitted by the SEC<br \/>\non Form 10-Q under the Exchange Act) and (iii) fairly presented the consolidated<br \/>\nfinancial position of Purchaser and its subsidiaries as at the respective dates<br \/>\nthereof and the consolidated results of Purchaser&#8217;s operations and cash flows<br \/>\nfor the periods indicated, except that unaudited interim financial statements<br \/>\nmay not contain footnotes and were or are subject to normal and recurring year-<br \/>\nend adjustments which would not have a Material Adverse Effect on Purchaser.<\/p>\n<p>     4.4 No Material Adverse Change. Since June 30, 1999, there has not been a<br \/>\nMaterial Adverse Effect on Purchaser.<\/p>\n<p>     4.5 Brokers&#8217; and Finders&#8217; Fees. Neither Purchaser nor its subsidiaries have<br \/>\nincurred, nor will they incur, directly or indirectly, any liability for<br \/>\nbrokerage or finders&#8217; fees or agents&#8217; commissions or any similar charges in<br \/>\nconnection with this Agreement or any transaction contemplated hereby.<\/p>\n<p>     4.6 Corporate Approvals. The Board of Directors of Purchaser has, as of the<br \/>\ndate of this Agreement, approved this Agreement and the transactions<br \/>\ncontemplated hereby. To the extent necessary, as of the Closing, the<br \/>\nStockholders of the Purchaser will have approved this Agreement and the<br \/>\ntransactions contemplated hereby.<\/p>\n<p>                                     -25-<\/p>\n<p>     4.7 Share Issuance. The shares representing the Share Payment when<br \/>\ndelivered will be duly authorized, fully paid and non-assessable.<\/p>\n<p>                                  ARTICLE 5.<\/p>\n<p>                       CONDUCT PRIOR TO THE CLOSING DATE<\/p>\n<p>     5.1 Conduct of Business of FAS. During the period from the date of this<br \/>\nAgreement and continuing until the earlier of the termination of this Agreement<br \/>\nor the Closing, FAS agrees to, and the Shareholders agree to cause FAS to, carry<br \/>\non FAS&#8217;s business in the usual, regular and ordinary course in substantially the<br \/>\nsame manner as heretofore conducted, to pay the debts and Taxes of FAS when due,<br \/>\nto pay or perform other obligations when due, and, to the extent consistent with<br \/>\nsuch business, use all reasonable efforts consistent with past practice and<br \/>\npolicies to preserve intact FAS&#8217;s present business organization, keep available<br \/>\nthe services of FAS&#8217;s present officers and employees and preserve FAS&#8217;s<br \/>\nrelationships with customers, suppliers, distributors, licensors, licensees and<br \/>\nothers having business dealings with it, all with the goal of preserving<br \/>\nunimpaired FAS&#8217;s goodwill and ongoing business at the Closing. Except as<br \/>\nexpressly contemplated by Part 5.1 of the FAS Schedules or as otherwise<br \/>\nexpressly provided in this Agreement, FAS shall not, and the Shareholders shall<br \/>\ncause FAS to not, without the prior written consent of Purchaser:<\/p>\n<p>          (a)  other than performing the Contracts listed in the FAS Schedules<br \/>\nin accordance with their terms existing on the date hereof, make any expenditure<br \/>\nor enter into any transaction exceeding $50,000 or any commitment or transaction<br \/>\nof the type described in Section 2.17 hereof;<\/p>\n<p>          (b)  sell, license or transfer to any person or entity of any rights<br \/>\nto any FAS Intellectual Property or enter into any agreement with respect to the<br \/>\nFAS Intellectual Property with any person or entity other than in the ordinary<br \/>\ncourse of business consistent with past practice;<\/p>\n<p>          (c)  amend or change its Articles of Incorporation or Bylaws;<\/p>\n<p>          (d)  revalue any of its assets, including without limitation writing<br \/>\ndown the value of inventory or writing off notes or accounts receivable other<br \/>\nthan in the ordinary course of business consistent with past practice;<\/p>\n<p>          (e)  issue, sell, grant, contract to issue, grant or sell, or<br \/>\nauthorize the issuance, delivery, sale or purchase of any shares of FAS Capital<br \/>\nStock or securities convertible into, or exercisable or exchangeable for, shares<br \/>\nof FAS Capital Stock, or any securities, warrants, options or rights to purchase<br \/>\nany of the foregoing;<\/p>\n<p>          (f)  declare, set aside or pay any dividends on or make any other<br \/>\ndistributions (whether in cash, stock or property) in respect of any FAS Capital<br \/>\nStock, or split, combine or reclassify any shares of FAS Capital Stock, or issue<br \/>\nor authorize the issuance of any other securities in respect of, in lieu of or<br \/>\nin substitution for shares of FAS Capital Stock, or repurchase, redeem, or<\/p>\n<p>                                     -26-<\/p>\n<p>otherwise acquire, directly or indirectly, any shares of FAS Capital Stock (or<br \/>\noptions, warrants or other rights convertible into, exercisable or exchangeable<br \/>\ntherefor);<\/p>\n<p>          (g)  grant any severance or termination pay (i) to any director or<br \/>\nofficer or (ii) to any employee, or increase in the salary or other compensation<br \/>\npayable or to become payable by FAS to any of its officers, directors, employees<br \/>\nor advisors, or declare, pay or make any commitment or obligation of any kind<br \/>\nfor the payment by FAS of a bonus or other additional salary or compensation to<br \/>\nany such person, or adopt or amend any employee benefit plan or enter into any<br \/>\nemployment contract other than in the ordinary course of business consistent<br \/>\nwith past practice;<\/p>\n<p>          (h)  sell, lease, license or otherwise dispose of any of the assets or<br \/>\nproperties of FAS which are not Intellectual Property other than in the ordinary<br \/>\ncourse of business and consistent with past practices, including but not limited<br \/>\nto the performance of obligations under contractual arrangements existing as of<br \/>\nthe date hereof set forth on the FAS Schedules, or create any security interest<br \/>\nin such assets or properties;<\/p>\n<p>          (i)  grant any loan to any person or entity except for accounts<br \/>\nreceivable in the ordinary course of business consistent with past practice,<br \/>\nincur any indebtedness or guarantee any indebtedness except for accounts payable<br \/>\nincurred in the ordinary course of business consistent with past practice, issue<br \/>\nor sell any debt securities, guarantee any debt securities of others, purchase<br \/>\nany debt securities of others or amend the terms of any outstanding agreements<br \/>\nrelated to borrowed money, except for advances to employees for travel and<br \/>\nbusiness expenses in the ordinary course of business consistent with past<br \/>\npractice;<\/p>\n<p>          (j)  amend in any material respect or otherwise modify (or agree to do<br \/>\nso), or violate the terms of any of the Contracts set forth or described in the<br \/>\nFAS Schedules or enter into any material Contract except in the ordinary course<br \/>\nof business consistent with past practice;<\/p>\n<p>          (k)  commence or settle any litigation;<\/p>\n<p>          (l)  acquire or agree to acquire by merging or consolidating with, or<br \/>\nby purchasing any assets or equity securities or, or by any other manner, any<br \/>\nbusiness or any corporation, partnership, association or other business<br \/>\norganization or division thereof, or otherwise acquire or agree to acquire any<br \/>\nassets which are material, individually or in the aggregate, to FAS&#8217;s business;<\/p>\n<p>          (m)  pay, discharge or satisfy, in an amount in excess of $50,000 (in<br \/>\nany one case) or $100,000 (in the aggregate), any claim, liability or obligation<br \/>\n(absolute, accrued, asserted or unasserted, contingent or otherwise), other than<br \/>\nthe payment, discharge or satisfaction of liabilities in the ordinary course of<br \/>\nbusiness and in a manner consistent with past practice;<\/p>\n<p>          (n)  make or change any material election in respect of Taxes, adopt<br \/>\nor change any accounting method in respect of Taxes, enter into any closing<br \/>\nagreement, settle any claim or<\/p>\n<p>                                     -27-<\/p>\n<p>assessment in respect of Taxes, or consent to any extension or waiver of the<br \/>\nlimitation period applicable to any claim or assessment in respect of Taxes;<\/p>\n<p>          (o)  terminate any employees other than for cause or encourage any<br \/>\nemployees to resign from FAS;<\/p>\n<p>          (p)  enter into any contract, purchase order or other agreement<br \/>\npursuant to which FAS would be required to book any amounts due thereunder as<br \/>\ndeferred revenue; or<\/p>\n<p>          (q)  take or agree in writing or otherwise to take any of the actions<br \/>\ndescribed in the preceding clauses (a) through (p) of this Section 5.1 or any<br \/>\nother action that would prevent FAS from performing or cause FAS not to perform<br \/>\nits covenants hereunder.<\/p>\n<p>     5.2 Exclusivity. Until the earlier of (i) the Closing or (ii) the date of<br \/>\ntermination of this Agreement pursuant to the provisions of Section 9.1 hereof,<br \/>\nFAS and the Shareholders, jointly and severally, agree that they shall not (nor<br \/>\nshall they permit any of their respective officers, directors, agents,<br \/>\nrepresentatives or affiliates to) directly or indirectly, take any of the<br \/>\nfollowing actions with any party other than Purchaser and its designees: (a)<br \/>\nsolicit, encourage, initiate or participate in any inquiry, negotiations or<br \/>\ndiscussions or enter into any agreement with respect to any offer or proposal to<br \/>\nacquire any portion of FAS&#8217;s business and properties or any shares of FAS<br \/>\nCapital Stock (whether or not outstanding) whether by merger, purchase of<br \/>\nassets, tender offer or otherwise, or effect any such transaction, (b) disclose<br \/>\nany information not customarily disclosed to such person concerning FAS&#8217;s<br \/>\nbusiness, technologies, or properties, or afford to any person or entity access<br \/>\nto its properties, technologies, books or records, not customarily afforded such<br \/>\naccess, (c) assist or cooperate with any person to make any proposal to purchase<br \/>\nall or any part of the FAS Capital Stock or FAS&#8217;s assets or (d) solicit,<br \/>\nnegotiate or enter into any agreement with any person providing for the<br \/>\nacquisition of FAS (whether by way of merger, purchase of assets, tender offer<br \/>\nor otherwise). In the event FAS or any Shareholder shall receive, prior to the<br \/>\nClosing or the termination of this Agreement, any offer or proposal, directly or<br \/>\nindirectly, of the type referred to in clause (a) or (c) above, or any request<br \/>\nfor disclosure or access pursuant to clause (b) above, FAS and the Shareholders<br \/>\nshall immediately inform Purchaser as to any such offer or proposal, including<br \/>\ninformation as to the identity of the offeror or the party making such offer or<br \/>\nproposal and the specific terms of such offer or proposal, as the case may be.<br \/>\nThe parties hereto agree that irreparable damage would occur in the event that<br \/>\nthe provisions of this Section 5.2 were not performed in accordance with their<br \/>\nspecific terms or were otherwise breached. It is accordingly agreed by FAS and<br \/>\nthe Shareholders that Purchaser shall be entitled to seek an injunction or<br \/>\ninjunctions to prevent breaches of the provisions of this Section 5.2 and to<br \/>\nenforce specifically the terms and provisions hereof in any court of the United<br \/>\nStates or any state having jurisdiction, this being in addition to any other<br \/>\nremedy to which Purchaser may be entitled at law or in equity. Without limiting<br \/>\nthe foregoing, it is understood that any violation of the restrictions set forth<br \/>\nin this Section 5.2 by any officer, director or employee of FAS or a Shareholder<br \/>\nor any investment banker, attorney or other advisor or representative of FAS or<br \/>\na Shareholder shall be deemed to be a breach of this Section 5.2.<\/p>\n<p>                                     -28-<\/p>\n<p>                                  ARTICLE 6.<\/p>\n<p>                             ADDITIONAL AGREEMENTS<\/p>\n<p>     6.1  Restrictions on Transfer<\/p>\n<p>          (a)  All certificates representing Common Stock of Purchaser and<br \/>\ndeliverable to any Shareholder pursuant to this Agreement and any certificates<br \/>\nsubsequently issued with respect thereto or in substitution therefor (including<br \/>\nany shares issued or issuable in respect of any such shares upon any stock<br \/>\nsplit, stock dividend, recapitalization, conversion or similar event) shall be<br \/>\nstamped or otherwise imprinted with legends in the following form:<\/p>\n<p>          THE SHARES REPRESENTED BY THIS CERTIFICATE HAVE NOT BEEN REGISTERED<br \/>\n          UNDER THE SECURITIES ACT OF 1933, AS AMENDED. THE SHARES REPRESENTED<br \/>\n          BY THIS CERTIFICATE MAY NOT BE SOLD OR TRANSFERRED IN THE ABSENCE OF<br \/>\n          SUCH REGISTRATION OR A LEGAL OPINION IN ACCORDANCE WITH A WRITTEN<br \/>\n          OPINION OF COUNSEL, REASONABLY ACCEPTABLE TO THE ISSUER IN FORM AND<br \/>\n          SUBSTANCE, THAT SUCH TRANSFER IS EXEMPT FROM REGISTRATION UNDER THE<br \/>\n          SECURITIES ACT OF 1933.<\/p>\n<p>          THE TRANSFER RESTRICTIONS APPLICABLE TO THESE SHARES ARE BINDING ON<br \/>\n          TRANSFEREES OF THESE SHARES.<\/p>\n<p>          (b)  The certificates evidencing the Share Payment Shares shall also<br \/>\nbear any legend required by the Commissioner of Corporations of the State of<br \/>\nCalifornia or such as are required pursuant to any state, local or foreign law<br \/>\ngoverning such securities.<\/p>\n<p>          (c)  The shares comprising the Share Payment will not be registered<br \/>\nunder the Securities Act.<\/p>\n<p>          (d)  No Shareholder shall be permitted to sell or otherwise dispose of<br \/>\nany of the shares comprising the Share Payment pursuant to this Agreement,<br \/>\nunless the resale of such shares has been registered under the Securities Act by<br \/>\nthe Purchaser or Purchaser receives an unqualified written opinion of counsel<br \/>\nreasonably acceptable to it stating that the proposed transfer of such shares<br \/>\nmay be effected without registration under the Securities Act.<\/p>\n<p>          (e)  Purchaser shall be entitled to impose &#8220;stop-transfer&#8221; orders with<br \/>\nthe transfer agent for its Common Stock to enforce the provisions of this<br \/>\nSection 6.1.<\/p>\n<p>          (f)  Each Shareholder agrees not to sell or otherwise transfer or<br \/>\ndispose of any shares of Purchaser Common Stock deliverable to pursuant to this<br \/>\nAgreement unless the transferee agrees to be bound by the restrictions of this<br \/>\nSection 6.1.<\/p>\n<p>                                     -29-<\/p>\n<p>     6.2 Access to Information. FAS shall afford, and the Shareholders shall<br \/>\ncause FAS to afford, Purchaser and its accountants, counsel and other<br \/>\nrepresentatives reasonable access during normal business hours during the period<br \/>\nprior to the Closing to (a) all of FAS&#8217;s properties, books, contracts,<br \/>\ncommitments and records, (b) all other information concerning the business,<br \/>\nproperties and personnel (subject to restrictions imposed by applicable law) of<br \/>\nFAS and (c) all key employees of FAS. FAS agrees, and the Shareholders shall<br \/>\ncause FAS, to provide to Purchaser and its accountants, counsel and other<br \/>\nrepresentatives copies of internal financial statements promptly upon request.<br \/>\nNo information or knowledge obtained in any investigation pursuant to this<br \/>\nSection 6.3 shall affect or be deemed to modify any representation or warranty<br \/>\ncontained herein or the conditions to the obligations of the parties to<br \/>\nconsummate the transactions contemplated by this Agreement.<\/p>\n<p>     6.3 Confidentiality. Each of the parties hereto hereby agrees that the<br \/>\ninformation obtained in any investigation pursuant to Section 6.2 hereof, or<br \/>\npursuant to the negotiation and execution of this Agreement or the effectuation<br \/>\nof the transactions contemplated hereby, shall be governed by the terms of the<br \/>\nConfidentiality Agreements, executed effective as of June 10, 1999, and<br \/>\nSeptember 2, 1999, respectively, between CNI and Purchaser (collectively, the<br \/>\n&#8220;Confidentiality Agreements&#8221;). Each Shareholder agrees to be bound by the terms<br \/>\nof the Confidentiality Agreements as if such Shareholder were a party to the<br \/>\nConfidentiality Agreements.<\/p>\n<p>     6.4 Expenses. Whether or not the transactions are consummated, all fees and<br \/>\nexpenses incurred in connection with the transactions contemplated hereby<br \/>\nincluding, without limitation, all legal, accounting, financial advisory,<br \/>\nconsulting and all other fees and expenses of third parties incurred by a party<br \/>\nhereto in connection with the negotiation and effectuation of the terms and<br \/>\nconditions of this Agreement and the transactions contemplated hereby or<br \/>\nthereby, shall be the obligation of the respective party incurring such fees and<br \/>\nexpenses.<\/p>\n<p>     6.5 Public Disclosure. Unless otherwise required by law, no disclosure<br \/>\n(whether or not in response to an inquiry) of the subject matter of this<br \/>\nAgreement shall be made by any party hereto unless approved by the other party<br \/>\nprior to release; provided, however, that such approval shall not be<br \/>\nunreasonably withheld, subject in the case of Purchaser, to Purchaser&#8217;s<br \/>\nobligation to comply with applicable securities laws and the rules of The Nasdaq<br \/>\nStock Market and, subject in the case of CNI, to CNI&#8217;s obligation to comply with<br \/>\napplicable securities laws and the rules of the New York Stock Exchange.<\/p>\n<p>     6.6 Consents. FAS shall use commercially reasonable efforts, and the<br \/>\nShareholders shall use commercially reasonable efforts to cause FAS, to obtain<br \/>\nthe consents, waivers and approvals under any of the Contracts required in<br \/>\nconnection with the transactions contemplated hereby, including all such<br \/>\nconsents, waivers and approvals set forth in FAS Schedules, so as to preserve<br \/>\nall rights of, and benefits to, Purchaser thereunder.<\/p>\n<p>     6.7 HSR Act. Purchaser, FAS and any applicable Shareholder each shall file<br \/>\nwith the United States Federal Trade Commission (&#8220;FTC&#8221;) and the Antitrust<br \/>\nDivision of the United States. <\/p>\n<p>                                     -30-<\/p>\n<p>Department of Justice (the &#8220;DOJ&#8221;) any Notification and Report Forms relating to<br \/>\nthe transactions contemplated herein required by the HSR Act. Each of the<br \/>\nparties hereto shall promptly (i) supply the others with any information which<br \/>\nmay be required in order to effectuate such filings and (ii) supply any<br \/>\nadditional information which may reasonably be required by the FTC or the DOJ.<\/p>\n<p>     6.8  FIRPTA Compliance. On the Closing Date, FAS shall deliver, and the<br \/>\nShareholders shall cause FAS to deliver, to Purchaser a properly executed<br \/>\nstatement in a form reasonably acceptable to Purchaser for purposes of<br \/>\nsatisfying Purchaser&#8217;s obligations under Treasury Regulation Section 1.1445-<br \/>\n2(c)(3).<\/p>\n<p>     6.9  Reasonable Efforts. Subject to the terms and conditions provided in<br \/>\nthis Agreement, each of the parties hereto shall use commercially reasonable<br \/>\nefforts to take promptly, or cause to be taken, all actions, and to do promptly,<br \/>\nor cause to be done, all things necessary, proper or advisable under applicable<br \/>\nlaws and regulations to consummate and make effective the transactions<br \/>\ncontemplated hereby, to obtain all necessary waivers, consents and approvals and<br \/>\nto effect all necessary registrations and filings (including any filings or<br \/>\nregistrations necessary to perfect Purchaser&#8217;s ownership of any FAS Registered<br \/>\nIntellectual Property after the Closing) and to remove any injunctions or other<br \/>\nimpediments or delays, legal or otherwise, in order to consummate and make<br \/>\neffective the transactions contemplated by this Agreement for the purpose of<br \/>\nsecuring to the parties hereto the benefits contemplated by this Agreement.<\/p>\n<p>     6.10 Notification of Certain Matters. FAS and the Shareholders shall give<br \/>\nprompt notice to Purchaser of (i) the occurrence or non-occurrence of any event,<br \/>\nthe occurrence or non-occurrence of which would cause any representation or<br \/>\nwarranty of FAS or the Shareholders contained in this Agreement to be untrue or<br \/>\ninaccurate, such that the condition set forth in Section 7.2(a) would not be<br \/>\nsatisfied and (ii) any failure of FAS or the Shareholders, as the case may be,<br \/>\nto comply with or satisfy in all material respects any covenant, condition or<br \/>\nagreement to be complied with or satisfied by it hereunder; provided, however,<br \/>\nthat the delivery of any notice pursuant to this Section 6.10 shall not limit or<br \/>\notherwise affect any remedies available to the party receiving such notice. No<br \/>\ndisclosure by FAS pursuant to this Section 6.10 shall be deemed to amend or<br \/>\nsupplement the FAS Schedules or prevent or cure any misrepresentation, breach of<br \/>\nwarranty or breach of covenant.<\/p>\n<p>     Purchaser shall give prompt notice to FAS and the Shareholders of (i) the<br \/>\noccurrence or non-occurrence of any event, the occurrence or non-occurrence of<br \/>\nwould cause any representation or warranty of Purchaser contained in this<br \/>\nAgreement to be untrue or inaccurate, such that the condition set forth in<br \/>\nSection 7.3(a) would not be satisfied and (ii) any failure of Purchaser to<br \/>\ncomply with or satisfy in all material respects any covenant, condition or<br \/>\nagreement to be complied with or satisfied by it hereunder; provided, however,<br \/>\nthat the delivery of any notice pursuant to this Section 6.10 shall not limit or<br \/>\notherwise affect any remedies available to the party receiving such notice. No<br \/>\ndisclosure by Purchaser pursuant to this Section 6.10 shall be deemed to amend<br \/>\nor supplement the Purchaser Schedules or prevent or cure any misrepresentation,<br \/>\nbreach of warranty or breach of covenant.<\/p>\n<p>                                     -31-<\/p>\n<p>     6.11  Cooperation of Independent Accountants. At Purchaser&#8217;s request, FAS<br \/>\nshall use commercially reasonable efforts, and the Stockholders shall use<br \/>\ncommercially reasonable efforts to cause FAS, to cause its independent<br \/>\naccountants, PricewaterhouseCoopers LLP, to provide assistance, to Purchaser,<br \/>\nits affiliates and successors and Purchaser&#8217;s independent accountants in<br \/>\nconnection with the filing of any (i) registration statement under the<br \/>\nSecurities Act (and any amendments or supplements thereto), including but not<br \/>\nlimited to, consenting to the inclusion of the HBF Audited Financials in the<br \/>\nregistration statement as required by Regulation S-X under the Exchange Act, and<br \/>\nproviding, at Purchaser&#8217;s expense, a &#8220;comfort letter&#8221; addressed to the<br \/>\nunderwriters containing such representations as the underwriters may reasonably<br \/>\nrequest and (ii) periodic or current reports required to be filed by Purchaser<br \/>\npursuant to the Exchange Act.<\/p>\n<p>     6.12  Employment Matters. FAS and the Shareholders shall use all reasonable<br \/>\nefforts to cause each existing employment agreement between FAS or its<br \/>\nsubsidiaries and an employee of FAS or its subsidiaries to be terminated as of<br \/>\nor before the Closing and shall use all reasonable efforts to obtain a release<br \/>\nfrom each such employee releasing Purchaser and FAS and their respective<br \/>\nsubsidiaries against any and all claims arising out of such employee&#8217;s<br \/>\nemployment arrangement.<\/p>\n<p>     6.13  Employment and Non-Competition Agreements. Prior the Closing, each<br \/>\nShareholder listed on Exhibit G shall deliver to Purchaser a duly executed<br \/>\nEmployment and Non-Competition Agreement and the Shareholders shall use all<br \/>\nreasonable efforts to deliver or cause to be delivered to Purchaser a duly<br \/>\nexecuted Employment and Non-Competition Agreement from each of the other<br \/>\nindividuals listed on Exhibit G. Prior to Closing, CNI shall deliver a duly<br \/>\nexecuted Non-Competition and Non-Solicitation Agreement and Richard Ganley shall<br \/>\ndeliver a duly executed Consulting Agreement.<\/p>\n<p>     6.14  Contingent Payment Agreements. Each of the Shareholders shall cause<br \/>\nany existing obligation of FAS or any of its subsidiaries to make payments to<br \/>\nsuch Shareholder based upon the financial performance of FAS or any of its<br \/>\nsubsidiaries to be terminated as of immediately prior to the Closing and shall<br \/>\nprovide a release from each such Shareholder releasing Purchaser, CNI and FAS<br \/>\nand their respective subsidiaries against any and all claims arising out of such<br \/>\ncontingent payment arrangement. FAS and the Shareholders shall use all<br \/>\nreasonable efforts to cause any other existing obligation of FAS to make<br \/>\npayments to any individual or entity based upon the financial performance of FAS<br \/>\nto be terminated as of immediately prior to the Closing and shall obtain a<br \/>\nrelease from each such individual or entity releasing Purchaser, CNI and FAS and<br \/>\ntheir respective subsidiaries against any and all claims arising out of such<br \/>\ncontingent payment arrangement.<\/p>\n<p>     6.15  Director Resignations. Each Shareholder who is a director, by<br \/>\nsignature below, hereby tenders resignation from the FAS Board of Directors,<br \/>\neffective on the Closing. Each Shareholder who has the right to appoint and<br \/>\nremove a director shall take all measures to remove all directors elected by<br \/>\nsuch Shareholder effective on the Closing.<\/p>\n<p>     6.16  Release. As of and following the Closing, each Shareholder, on behalf<br \/>\nof himself, herself or itself, as the case may be, and his, her or its<br \/>\nrespective heirs, family members, executors,<\/p>\n<p>                                     -32-<\/p>\n<p>successors and assigns, hereby fully and forever releases HBF and FAS, and their<br \/>\nrespective officers, directors, employees, investors, shareholders,<br \/>\nadministrators, affiliates, divisions, subsidiaries, predecessor and successor<br \/>\ncorporations, and assigns (collectively, the &#8220;Released Parties&#8221;), from, and<br \/>\nagrees not to sue concerning, any claim, duty, obligation or cause of action<br \/>\nrelating to any matters of any kind, whether presently known or unknown,<br \/>\nsuspected or unsuspected, that he, she or it may possess arising from any<br \/>\nomissions, acts or facts that have occurred up until the Closing (other than<br \/>\nwith respect to claims for payment of ordinary course salary not in arrears as<br \/>\nof the date hereof), including:<\/p>\n<p>          (a)  any and all claims arising under Shareholder&#8217;s employment<br \/>\narrangements or employment relationship with CNI, HBF or FAS and their<br \/>\nrespective subsidiaries;<\/p>\n<p>          (b)  any and all claims arising under that certain Stockholder&#8217;s<br \/>\nAgreement by and among CNI, HBF and certain shareholders of HBF (&#8220;HBF<br \/>\nStockholder&#8217;s Agreement&#8221;); that certain Earn-Out Agreement between HBF, National<br \/>\nSchool Reporting Services, Inc. (&#8220;NSRS&#8221;) (&#8220;NSRS Earn-Out Agreement&#8221;), and the<br \/>\nformer stockholders of NSRS; that certain Stockholder&#8217;s Agreement by and among<br \/>\nCNI and the former stockholders of FAS (the &#8220;FAS Stockholder&#8217;s Agreement&#8221;), and<br \/>\nany other bonus sharing, earn-out or contingent payment arrangement to which<br \/>\nHBF, FAS or any of their respective subsidiaries is a party (each, a &#8220;Contingent<br \/>\nPayment Arrangement&#8221;), and any share repurchase, buyback or similar arrangement<br \/>\nbetween such Shareholder to which HBF or FAS or any of their respective<br \/>\nsubsidiaries is party (each, a &#8220;Buyback Arrangement&#8221;); and<\/p>\n<p>          (c)  any and all claims relating to, or arising from, Shareholder&#8217;s<br \/>\nacquisition of shares of stock of HBF or FAS or any of their subsidiaries,<br \/>\nincluding any claims for fraud, misrepresentation, breach of fiduciary duty,<br \/>\nbreach of duty under applicable state corporate law, and securities fraud under<br \/>\nany state or federal law.<\/p>\n<p>     Shareholder agrees that the releases set forth in this section shall be and<br \/>\nremain in effect in all respects as a complete general release as to the matters<br \/>\nreleased. This release does not extend to any obligations incurred under this<br \/>\nAgreement. Each Shareholder represents that he, she or it, as the case may be,<br \/>\nis not aware of any claims against the Released Parties other than the claims<br \/>\nreleased by this Agreement. Each Shareholder acknowledges that he, she or it, as<br \/>\nthe case may be, has been advised by legal counsel and is familiar with the<br \/>\nprovisions of California Civil Code Section 1542, which provides as follows:<\/p>\n<p>          A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR DOES<br \/>\n          NOT KNOW OR SUSPECT TO EXIST IN HIS FAVOR AT THE TIME OF EXECUTING THE<br \/>\n          RELEASE, WHICH IF KNOWN BY HIM MUST HAVE MATERIALLY AFFECTED HIS<br \/>\n          SETTLEMENT WITH THE DEBTOR.<\/p>\n<p>                                     -33-<\/p>\n<p>     Shareholder, being aware of said code section, agrees to expressly waive<br \/>\nany rights he, she or it, as the case may be, may have thereunder, as well as<br \/>\nunder any other statute or common law principles of similar effect.<\/p>\n<p>     6.17  Termination of Employment, Contingent Payment and Buyback<br \/>\nArrangements. If and to the extent a Shareholder is a party to any employment<br \/>\narrangement with HBF, FAS or any of their subsidiaries, the HBF Stockholder&#8217;s<br \/>\nAgreement, the NSRS Earn-Out Agreement, the FAS Stockholder&#8217;s Agreement, a<br \/>\nContingent Payment Arrangement and\/or a Buyback Arrangement, such Shareholder<br \/>\nagrees that such employment arrangement, HBF Stockholder&#8217;s Agreement, NSRS Earn-<br \/>\nOut Agreement, FAS Stockholder&#8217;s Agreement, Contingent Payment Arrangement or<br \/>\nBuyback Arrangement, as the case may be, shall terminate and be of no further<br \/>\nforce effect at and following the Closing.<\/p>\n<p>     6.18  Morgan Stanley Consent. Purchaser will use commercially reasonable<br \/>\nefforts to obtain the written consent to issue the Shares of Morgan Stanley &amp; Co. Incorporated under the terms of Section 2 of that certain underwriting<br \/>\nagreement dated August 4, 1999 by and among the Purchaser and Morgan Stanley &amp; Co. Incorporated, Donaldson Lufkin &amp; Jenrette Securities Corporation, BancBoston<br \/>\nRobertson Stephens Inc., Merrill Lynch, Pierce, Fenner &amp; Smith Incorporated as<br \/>\nrepresentatives of the several underwriters named in Schedule I thereto (the<br \/>\n&#8220;Underwriter Consent&#8221;).<\/p>\n<p>                                  ARTICLE 7.<\/p>\n<p>               CONDITIONS TO THE PURCHASE AND SALE OF THE SHARES<\/p>\n<p>     7.1  Conditions to Obligations of the Parties. The respective obligations<br \/>\nof each party to this Agreement to the purchase and sale of the securities set<br \/>\nforth in Section 1 shall be subject to the satisfaction at or prior to the<br \/>\nClosing of the following conditions:<\/p>\n<p>           (a)  No Injunctions or Restraints; Illegality. No temporary<br \/>\nrestraining order, preliminary or permanent injunction or other order issued by<br \/>\nany court of competent jurisdiction or other legal restraint or prohibition<br \/>\npreventing the consummation of the transaction contemplated by this Agreement<br \/>\nshall be in effect, nor shall any proceeding brought by an administrative agency<br \/>\nor commission or other governmental authority or instrumentality, domestic or<br \/>\nforeign, seeking any of the foregoing be pending; nor shall there be any action<br \/>\ntaken, or any statute, rule, regulation or order enacted, entered, enforced or<br \/>\ndeemed applicable to the transactions contemplated hereby, which makes the<br \/>\nconsummation of the transactions contemplated hereby illegal.<\/p>\n<p>           (b)  Permits. All approvals from government authorities, including<br \/>\nany requisite Blue Sky approvals or HSR Act approvals, which are appropriate or<br \/>\nnecessary for the consummation of the transactions contemplated by this<br \/>\nAgreement, shall have been obtained.<\/p>\n<p>                                     -34-<\/p>\n<p>          (c)  The Homebuyer&#8217;s Fair, Inc. Closing. All of the conditions to the<br \/>\nobligations of the parties to consummate the transactions contemplated by the<br \/>\nStock Purchase Agreement dated as of the date hereof among Purchaser, HBF, the<br \/>\nShareholders of HBF and CNI, as Shareholder Agent (the &#8220;HBF Agreement&#8221;) shall<br \/>\nhave been satisfied or waived.<\/p>\n<p>     7.2  Conditions to Obligations of Purchaser. The obligation of Purchaser to<br \/>\nconsummate and effect this Agreement and the transactions contemplated hereby<br \/>\nshall be subject to the satisfaction at or prior to the Closing Date of each of<br \/>\nthe following conditions, any of which may be waived, in writing, exclusively by<br \/>\nPurchaser:<\/p>\n<p>          (a)  Representations and Warranties. Each representation and warranty<br \/>\nof FAS and the Shareholders contained in this Agreement (i) shall have been true<br \/>\nand correct as of the date of this Agreement and (ii) shall be true and correct<br \/>\non and as of the Closing Date with the same force and effect as if made on the<br \/>\nClosing Date except, (A) in each case, or in the aggregate, as does not<br \/>\nconstitute a Material Adverse Effect on FAS or materially affect any of the<br \/>\nShareholders&#8217; ability to consummate the transactions contemplated hereby;<br \/>\nprovided, however, such Material Adverse Effect qualification shall be<br \/>\ninapplicable with respect to the representations and warranties contained in<br \/>\nSection 2.2, the first three sentences of Section 2.4(a), Section 3.1 and the<br \/>\nfirst three sentences of Section 3.2(a) (which representations and warranties<br \/>\nshall have been, and shall be, true and correct in all respects) and (B) for<br \/>\nthose representations and warranties which address matters only as of a<br \/>\nparticular date (which representations shall have been true and correct (subject<br \/>\nto the qualifications set forth in the preceding clause (A)) as of such<br \/>\nparticular date) (it being understood that, for purposes of determining the<br \/>\naccuracy of such representations and warranties, any update of or modification<br \/>\nto the FAS Schedules made or purported to have been made after the execution of<br \/>\nthis Agreement shall be disregarded). Purchaser shall have received a<br \/>\ncertificate with respect to the foregoing signed on behalf of FAS by an<br \/>\nauthorized executive officer of FAS.<\/p>\n<p>          (b)  Agreements and Covenants. FAS and the Shareholders shall have<br \/>\nperformed or complied in all material respects with all agreements and covenants<br \/>\nrequired by this Agreement to be performed or complied with by them on or prior<br \/>\nto the Closing Date, and Purchaser shall have received a certificate to such<br \/>\neffect signed on behalf of FAS by an authorized executive officer of FAS.<\/p>\n<p>          (c)  Legal Opinion. Purchaser shall have received an opinion from<br \/>\nSnell &amp; Wilmer L.L.P., legal counsel to CNI, substantially in the form attached<br \/>\nhereto as Exhibit H.<\/p>\n<p>          (d)  Employment and Non-Competition. Each of the individuals set forth<br \/>\non Exhibit G shall have entered into the Employment and Non-Competition<br \/>\nAgreement, and such agreements shall be in full force and effect.<\/p>\n<p>          (e)  Non-Competition and Non-Solicitation Agreement. CNI shall have<br \/>\nentered into the Non-Competition and Non-Solicitation Agreement, and such<br \/>\nagreement shall be in full force and effect.<\/p>\n<p>                                     -35-<\/p>\n<p>          (f)  Third Party Consents. The consents, waivers and approvals listed<br \/>\nin the FAS Schedules shall have been obtained.<\/p>\n<p>          (g)  Termination of Employment Agreements. Each existing employment<br \/>\nagreement between FAS or its subsidiaries and an employee of FAS or its<br \/>\nsubsidiaries shall have been terminated and Purchaser shall have obtained a<br \/>\nrelease from each such employee in form and substance satisfactory to Purchaser<br \/>\nreleasing Purchaser and FAS and their respective subsidiaries against any and<br \/>\nall claims arising out of such employee&#8217;s employment arrangement.<\/p>\n<p>          (h)  Termination of Contingent Payment Obligations. All obligations of<br \/>\nthe Purchaser or FAS or their respective subsidiaries to make payments to based<br \/>\nupon the financial performance of FAS shall have been terminated and Purchaser<br \/>\nshall have obtained releases in form and substance satisfactory to it to such<br \/>\neffect.<\/p>\n<p>          (i)  Richard Ganley Consulting Agreement. Richard Ganley shall have<br \/>\nentered into the Consulting Agreement, and such agreement shall be in full force<br \/>\nand effect.<\/p>\n<p>     7.3  Conditions to the Obligations of the Shareholders. The obligations of<br \/>\nthe Shareholders to consummate and effect this Agreement and the transactions<br \/>\ncontemplated hereby shall be subject to the satisfaction at or prior to the<br \/>\nClosing Date of each of the following conditions, any of which may be waived, in<br \/>\nwriting, exclusively by the Shareholders acting together:<\/p>\n<p>          (a)  Representations and Warranties. Each representation and warranty<br \/>\nof Purchaser contained in this Agreement (i) shall have been true and correct as<br \/>\nof the date of this Agreement and (ii) shall be true and correct on and as of<br \/>\nthe Closing Date with the same force and effect as if made on the Closing Date<br \/>\nexcept, (A) in each case, or in the aggregate, as does not constitute a Material<br \/>\nAdverse Effect on Purchaser; provided, however, such Material Adverse Effect<br \/>\nqualification shall be inapplicable with respect to the representations and<br \/>\nwarranties contained in the first three sentences of Section 4.1(a) and Section<br \/>\n4.7 (which representations and warranties shall have been, and shall be, true<br \/>\nand correct in all respects) and (B) for those representations and warranties<br \/>\nwhich address matters only as of a particular date (which representations shall<br \/>\nhave been true and correct (subject to the qualifications set forth in the<br \/>\npreceding clause (A)) as of such particular date) (it being understood that, for<br \/>\npurposes of determining the accuracy of such representations and warranties, any<br \/>\nupdate of or modification to the Purchaser Schedules made or purported to have<br \/>\nbeen made after the execution of this Agreement shall be disregarded). The<br \/>\nShareholders shall have received a certificate with respect to the foregoing<br \/>\nsigned on behalf of Purchaser by an authorized executive officer of Purchaser.<\/p>\n<p>          (b)  Agreements and Covenants. Purchaser shall have performed or<br \/>\ncomplied in all material respects with all agreements and covenants required by<br \/>\nthis Agreement to be performed or complied with by them on or prior to the<br \/>\nClosing Date, and the Shareholders shall have received a certificate to such<br \/>\neffect signed on behalf of Purchaser by an authorized executive officer of<br \/>\nPurchaser.<\/p>\n<p>                                     -36-<\/p>\n<p>          (c)  Pledge Agreement. Purchaser shall have entered into the Pledge<br \/>\nAgreement, and such agreement shall be in full force and effect.<\/p>\n<p>          (d)  Legal Opinion. The Shareholders shall have received an opinion<br \/>\nfrom Fenwick &amp; West LLP, legal counsel to Purchaser, substantially in the form<br \/>\nattached hereto as Exhibit I.<\/p>\n<p>          (e)  Underwriter Consent. The Shareholders shall have obtained from<br \/>\nPurchaser the Underwriter Consent.<\/p>\n<p>                                  ARTICLE 8.<\/p>\n<p>                  SURVIVAL OF REPRESENTATIONS AND WARRANTIES<\/p>\n<p>     8.1  Survival of Representations and Warranties. All representations and<br \/>\nwarranties in this Agreement or in any instrument delivered pursuant to this<br \/>\nAgreement shall survive the Closing and continue until 5:00 p.m., California<br \/>\ntime, on the first anniversary of the Closing Date (the &#8220;Expiration Date&#8221;).<\/p>\n<p>     8.2  Indemnification.<\/p>\n<p>          (a)  Indemnification. The Shareholders shall severally indemnify<br \/>\nPurchaser for any claims, losses, liabilities, deficiencies, costs and expenses,<br \/>\nincluding reasonable attorneys&#8217; fees and expenses and expenses of investigation<br \/>\nand defense, net of any benefits or proceeds of insurance (hereinafter<br \/>\nindividually a &#8220;Loss&#8221; and collectively &#8220;Losses&#8221;) incurred by Purchaser, its<br \/>\nofficers, directors, or affiliates (including FAS) as a result of (i) any<br \/>\ninaccuracy or breach of a representation or warranty of FAS or the Shareholders<br \/>\ncontained herein (as modified by FAS Schedules) or (ii) any failure by FAS to<br \/>\nperform or comply with any covenant contained herein. Purchaser, FAS and the<br \/>\nShareholders each acknowledge that such Losses, if any, would relate to<br \/>\nunresolved contingencies existing at the Closing Date, which if resolved at the<br \/>\nClosing Date would have led to a reduction in the aggregate Total Consideration.<br \/>\nNothing herein shall limit the liability of FAS or the Shareholders for any<br \/>\nbreach of any representation, warranty or covenant if the transactions<br \/>\ncontemplated hereby do not close.<\/p>\n<p>          (b)  Right of Set-Off; Limitations Thereon. Purchaser shall have the<br \/>\nright to recover Losses indemnifiable pursuant to Section 8.2(a) by means of a<br \/>\nright of set-off pro rata against the principal amount of any of the Notes and<br \/>\nany interest paid or payable in respect of such principal amount (the &#8220;Set-Off<br \/>\nRight&#8221;). In the case of Losses relating to a breach of representations and<br \/>\nwarranties set forth in Sections 2.2, 2.3, 2.4, 2.9(c), 2.9(d), 2.9(h), 3.1 and<br \/>\n3.2, Purchaser may bring action directly against the former Shareholders (the<br \/>\n&#8220;Direct Right&#8221;) in the manner set forth in Sections 8.2(d) and 8.2(e) below.<br \/>\nPurchaser may not utilize the Set-Off Right or the Direct Right unless and until<br \/>\nOfficer&#8217;s Certificate(s) (as defined below) identifying Losses, the aggregate<br \/>\namount<\/p>\n<p>                                     -37-<\/p>\n<p>of which, when aggregated with Losses (under and as defined in the HBF<br \/>\nAgreement) exceed $200,000, have been delivered to the Shareholder Agent as<br \/>\nprovided in paragraph (d); in such case, Purchaser may utilize the Set-off Right<br \/>\nor the Direct Right for the total of its Losses; provided, however, Purchaser<br \/>\nshall not be entitled to utilize the Set-off Right for Losses which exceed, when<br \/>\naggregated with Losses (as defined in the HBF Agreement) for which the Set-off<br \/>\nRight has been utilized, $8.5 million. Notwithstanding the foregoing, in the<br \/>\nevent that Purchaser shall set off any amounts against the Note an amount in<br \/>\nexcess of the amount of an indemifiable Loss, following the determination of<br \/>\namount of the indemnifiable Loss in accordance with Sections 8.2(d) and 8.2(e)<br \/>\nbelow, Purchaser shall pay to the holders of the Notes the amount of such<br \/>\nexcess, together with interest accrued on the amount of such excess from the<br \/>\nMaturity Date (as defined in the Notes) to the date of such payment at a rate<br \/>\nequal to ten and seven-eighths percent (10.875%) per annum, computed based on<br \/>\nthe basis of the actual number of days elapsed and a year of 365 days.<\/p>\n<p>          (c)  Limited Remedy. Except for claims with respect to breaches of the<br \/>\nrepresentations and warranties set forth in Sections 2.2, 2.3, 2.4, 2.9(c)<br \/>\n2.9(d), 2.9(h), 3.1 and 3.2, the Set-off Right shall be Purchaser&#8217;s exclusive<br \/>\nremedy for Losses after the Closing. With respect to breaches of the<br \/>\nrepresentations and warranties set forth in Sections 2.2, 2.3, 2.4, 2.9(c),<br \/>\n2.9(d), 2.9(h), 3.1 and 3.2, the maximum amount the Purchaser shall be entitled<br \/>\nto recover from each Shareholder shall not exceed the aggregate of such<br \/>\nShareholder&#8217;s Allocated Portion of the Total Consideration set forth in Exhibit<br \/>\nA hereof and such Shareholder&#8217;s Allocated Portion of Total Consideration set<br \/>\nforth in Exhibit A of the HBF Agreement.<\/p>\n<p>          (d)  Set-Off Claims. In connection with utilizing its Set-Off Right or<br \/>\nDirect Right, Purchaser shall deliver to the Shareholder Agent a certificate<br \/>\nsigned by any officer of Purchaser (an &#8220;Officer&#8217;s Certificate&#8221;): (A) stating<br \/>\nthat Purchaser has paid or properly accrued or reasonably anticipates that it<br \/>\nwill have to pay or accrue Losses, and (B) specifying in reasonable detail the<br \/>\nindividual items of Losses included in the amount so stated, the date each such<br \/>\nitem was paid or properly accrued, or the basis for such anticipated liability,<br \/>\nand the nature of the misrepresentation, breach of warranty or covenant to which<br \/>\nsuch item is related.<\/p>\n<p>          (e)  Resolution of Conflicts; Arbitration.<\/p>\n<p>                    (i)  In case the Shareholder Agent shall object in writing<br \/>\nto any claim or claims made in any Officer&#8217;s Certificate, the Shareholder Agent<br \/>\nand Purchaser shall attempt in good faith to agree upon the rights of the<br \/>\nrespective parties with respect to each of such claims.<\/p>\n<p>                    (ii) If no such agreement can be reached after good faith<br \/>\nnegotiation, either Purchaser or the Shareholder Agent may demand arbitration of<br \/>\nthe matter unless the amount of the damage or loss is at issue in pending<br \/>\nlitigation with a third party, in which event arbitration shall not be commenced<br \/>\nuntil such amount is ascertained or both parties agree to arbitration; and in<br \/>\neither such event the matter shall be settled by arbitration conducted by three<br \/>\narbitrators. Purchaser and the Shareholder Agent shall each select one<br \/>\narbitrator, and the two arbitrators so selected shall select a third arbitrator.<br \/>\nThe arbitrators shall set a limited time period and establish procedures<\/p>\n<p>                                     -38-<\/p>\n<p>designed to reduce the cost and time for discovery while allowing the parties an<br \/>\nopportunity, adequate in the sole judgment of the arbitrators, to discover<br \/>\nrelevant information from the opposing parties about the subject matter of the<br \/>\ndispute. The arbitrators shall rule upon motions to compel or limit discovery<br \/>\nand shall have the authority to impose sanctions, including attorneys&#8217; fees and<br \/>\ncosts, to the extent as a court of competent law or equity, if the arbitrators<br \/>\ndetermine that discovery was sought without substantial justification or that<br \/>\ndiscovery was refused or objected to without substantial justification. The<br \/>\ndecision of a majority of the three arbitrators as to the validity and amount of<br \/>\nany claim in such Officer&#8217;s Certificate shall be binding and conclusive upon the<br \/>\nparties to this Agreement. Such decision shall be written and shall be supported<br \/>\nby written findings of fact and conclusions which shall set forth the award,<br \/>\njudgment, decree or order awarded by the arbitrators.<\/p>\n<p>                    (iii)  Judgment upon any award rendered by the arbitrators<br \/>\nmay be entered in any court having jurisdiction. Any such arbitration shall be<br \/>\nheld in Santa Clara County, California under the rules then in effect of the<br \/>\nAmerican Arbitration Association. For purposes of this Section 8.2(e), in any<br \/>\narbitration hereunder in which any claim or the amount thereof stated in the<br \/>\nOfficer&#8217;s Certificate is at issue, Purchaser shall be deemed to be the Non-<br \/>\nPrevailing Party in the event that the arbitrators award Purchaser less than the<br \/>\nsum of one-half (1\/2) of the disputed amount plus any amounts not in dispute;<br \/>\notherwise, the former Shareholders as represented by the Shareholder Agent shall<br \/>\nbe deemed to be the Non-Prevailing Party. The Non-Prevailing Party to an<br \/>\narbitration shall pay its own expenses, the fees of each arbitrator, the<br \/>\nadministrative costs of the arbitration and the expenses, including without<br \/>\nlimitation, reasonable attorneys&#8217; fees and costs, incurred by the other party to<br \/>\nthe arbitration.<\/p>\n<p>               (f)  Shareholder Agent; Power of Attorney.<\/p>\n<p>                    (i)    At the Closing, effective upon such vote, and without<br \/>\nfurther act of any Shareholder, CNI (Attention: Thomas K. MacGillivray) shall be<br \/>\nappointed as agent and attorney-in-fact (the &#8220;Shareholder Agent&#8221;) for each<br \/>\nShareholder of FAS, for and on behalf of Shareholders of FAS, to give and<br \/>\nreceive notices and communications to object to Purchaser&#8217;s assertion of its<br \/>\nSet-off Right and Direct Right, to agree to, negotiate, enter into settlements<br \/>\nand compromises of, and demand arbitration and comply with orders of courts and<br \/>\nawards of arbitrators with respect to such claims, and to take all actions<br \/>\nnecessary or appropriate in the judgment of Shareholder Agent for the<br \/>\naccomplishment of the foregoing. Such agency may be changed by the former<br \/>\nShareholders of FAS from time to time upon not less than thirty (30) days prior<br \/>\nwritten notice to Purchaser; provided that the Shareholder Agent may not be<br \/>\nremoved unless holders of a two-thirds interest of the Shareholders&#8217; shares<br \/>\nagree to such removal and to the identity of the substituted agent. Any vacancy<br \/>\nin the position of Shareholder Agent may be filled by approval of the holders of<br \/>\na majority in interest of the Shareholders&#8217; shares. No bond shall be required of<br \/>\nthe Shareholder Agent, and the Shareholder Agent shall not receive compensation<br \/>\nfor his or her services. Notices or communications to or from the Shareholder<br \/>\nAgent shall constitute notice to or from each of the Shareholders of FAS.<\/p>\n<p>                                     -39-<\/p>\n<p>               (ii) The Shareholder Agent shall not be liable for any act done<br \/>\nor omitted hereunder as Shareholder Agent while acting in good faith and in the<br \/>\nexercise of reasonable judgment. The former Shareholders shall severally<br \/>\nindemnify the Shareholder Agent and hold the Shareholder Agent harmless against<br \/>\nany loss, liability or expense incurred without gross negligence or bad faith on<br \/>\nthe part of the Shareholder Agent and arising out of or in connection with the<br \/>\nacceptance or administration of the Shareholder Agent&#8217;s duties hereunder,<br \/>\nincluding the reasonable fees and expenses of any legal counsel retained by the<br \/>\nShareholder Agent.<\/p>\n<p>          (g)  Actions of the Shareholder Agent. A decision, act, consent or<br \/>\ninstruction of the Shareholder Agent shall constitute a decision of all the<br \/>\nformer Shareholders and shall be final, binding and conclusive upon each of such<br \/>\nformer Shareholders and Purchaser may rely upon any such decision, act, consent<br \/>\nor instruction of the Shareholder Agent as being the decision, act, consent or<br \/>\ninstruction of each every such former Shareholder. Purchaser is hereby relieved<br \/>\nfrom any liability to any person for any acts done by them in accordance with<br \/>\nsuch decision, act, consent or instruction of the Shareholder Agent.<\/p>\n<p>          (h)  Third-Party Claims. In the event Purchaser becomes aware of a<br \/>\nthird-party claim which Purchaser believes may result in an indemnity claim<br \/>\n(including those relating to Taxes), Purchaser shall promptly notify the<br \/>\nShareholder Agent of such claim, and the Shareholder Agent, as representative<br \/>\nfor the former Shareholders shall be entitled, at the former Shareholders&#8217;<br \/>\nexpense, to participate in any defense of such claim. Purchaser shall have the<br \/>\nright in its sole discretion to settle any such claim. In the event that the<br \/>\nShareholder Agent has consented (which consent shall not be unreasonably<br \/>\nwithheld) to any such settlement or in the event the Shareholder Agent<br \/>\nunreasonably withheld its consent, neither the Shareholder Agent nor any<br \/>\nShareholder shall have power or authority to object under any provision of this<br \/>\nArticle 8 to the amount of any such claim by Purchaser. If the Shareholder Agent<br \/>\nhas not consented to the settlement, in the event that the arbitrators, in<br \/>\naccordance with Section 8.2(e)(ii), determine that the withholding of consent<br \/>\nwas reasonable and the settlement amount was unreasonable based upon the facts<br \/>\nand circumstances existing at the time of such settlement, the arbitrators shall<br \/>\ndetermine the appropriate settlement for purposes of Sections 8.2(b) and 8.2(c)<br \/>\nabove.<\/p>\n<p>          (i)  No Right to Indemnity or Contribution. The Shareholders shall<br \/>\nhave no contribution, indemnity or similar right against FAS with respect to any<br \/>\nclaim by the Purchaser for indemnification pursuant to this Article 8.<\/p>\n<p>                                  ARTICLE 9.<\/p>\n<p>                       TERMINATION, AMENDMENT AND WAIVER<\/p>\n<p>  9.1  Termination.  Except as provided in Section 9.2 below, this Agreement may<br \/>\nbe terminated and the transactions contemplated hereby abandoned at any time<br \/>\nprior to the Effective Time:<\/p>\n<p>                                     -40-<\/p>\n<p>          (a)  by mutual consent of each of the parties hereto (other than the<br \/>\nShareholder Agent);<\/p>\n<p>          (b)  by Purchaser or FAS and the Shareholders acting together if: (i)<br \/>\nthe Effective Time has not occurred by the date that is 100 days following but<br \/>\nnot including the date of this Agreement (the &#8220;End Date&#8221;); provided, however,<br \/>\nthat the right to terminate this Agreement under this Section 9.1(b)(i), shall<br \/>\nnot be available to any party whose action or failure to act has been a<br \/>\nprincipal cause of or resulted in the failure of the transactions contemplated<br \/>\nby this Agreement to occur on or before such date and such action or failure to<br \/>\nact constitutes a breach of this Agreement; (ii) there shall be a final<br \/>\nnonappealable order of a federal or state court in effect preventing<br \/>\nconsummation of the transactions contemplated by this Agreement; or (iii) there<br \/>\nshall be any statute, rule, regulation or order enacted, promulgated or issued<br \/>\nor deemed applicable to the transactions contemplated by this Agreement by any<br \/>\nGovernmental Entity that would make consummation of the transaction contemplated<br \/>\nby this Agreement illegal;<\/p>\n<p>          (c)  by Purchaser if there shall be any action taken other than by<br \/>\nPurchaser or at Purchaser&#8217;s behest, or any statute, rule, regulation or order<br \/>\nenacted, promulgated or issued or deemed applicable to the transactions<br \/>\ncontemplated by this Agreement by any Governmental Entity, which would: (i)<br \/>\nprohibit Purchaser&#8217;s ownership or operation of any portion of the business of<br \/>\nFAS or (ii) compel Purchaser to dispose of or hold separate all or a portion of<br \/>\nthe business or assets of FAS or Purchaser as a result of the transactions<br \/>\ncontemplated hereby;<\/p>\n<p>          (d)  by Purchaser, upon a breach of any representation, warranty,<br \/>\ncovenant or agreement on the part of FAS or any Shareholder set forth in this<br \/>\nAgreement, or if any representation or warranty of FAS or any Shareholder shall<br \/>\nhave become untrue, in either case such that the conditions set forth in Section<br \/>\n7.2(a) or Section 7.2(b) would not be satisfied as of the time of such breach or<br \/>\nas of the time such representation or warranty shall have become untrue,<br \/>\nprovided that if such inaccuracy in FAS&#8217;s or any Shareholder representations and<br \/>\nwarranties or breach by FAS or any Shareholder is curable by FAS or the<br \/>\nShareholder, as the case may be, through the exercise of either of his, her or<br \/>\nits commercially reasonable efforts, then Purchaser may not terminate this<br \/>\nAgreement under this Section 9.1(d) prior to the End Date, provided FAS or such<br \/>\nShareholder, as the case may be, continues to exercise commercially reasonable<br \/>\nefforts to cure such breach (it being understood that Purchaser may not<br \/>\nterminate this Agreement pursuant to this Section 9.1(d) if it shall have<br \/>\nmaterially breached this Agreement or if such breach by FAS or such Shareholder,<br \/>\nas the case may be, is cured prior to the End Date);<\/p>\n<p>          (e)  by FAS and the Shareholders acting together, upon a breach of any<br \/>\nrepresentation, warranty, covenant or agreement on the part of Purchaser set<br \/>\nforth in this Agreement, or if any representation or warranty of Purchaser shall<br \/>\nhave become untrue, in either case such that the conditions set forth in Section<br \/>\n7.3(a) or Section 7.3(b) would not be satisfied as of the time of such breach or<br \/>\nas of the time such representation or warranty shall have become untrue,<br \/>\nprovided, that if such inaccuracy in Purchaser&#8217;s representations and warranties<br \/>\nor breach by Purchaser is<\/p>\n<p>                                     -41-<\/p>\n<p>curable by Purchaser through the exercise of its commercially reasonable<br \/>\nefforts, then FAS and the Shareholders may not terminate this Agreement under<br \/>\nthis Section 9.1(e) prior to the End Date, provided Purchaser continues to<br \/>\nexercise commercially reasonable efforts to cure such breach (it being<br \/>\nunderstood that FAS and the Shareholders may not terminate this Agreement<br \/>\npursuant to this Section 9.1(e) if any of them shall have materially breached<br \/>\nthis Agreement or if such breach by the Purchaser is cured prior to the End<br \/>\nDate).<\/p>\n<p>     Where action is taken to terminate this Agreement pursuant to this Section<br \/>\n9.1, it shall be sufficient (and required) for such action to be authorized by<br \/>\nthe Board of Directors (as applicable) of the party taking such action.<\/p>\n<p>     9.2  Effect of Termination.  In the event of termination of this Agreement<br \/>\nas provided in Section 9.1, this Agreement shall forthwith become void and there<br \/>\nshall be no liability or obligation on the part of Purchaser, FAS, the<br \/>\nShareholders or their respective officers, directors, shareholders or<br \/>\nstockholders provided, however, that each party shall remain liable for any<br \/>\nbreaches of this Agreement prior to its termination; and provided, further, that<br \/>\nthe provisions of Sections 6.3, 6.4, 6.5, this Section 9.2 and Article 10 of<br \/>\nthis Agreement shall remain in full force and effect and survive any termination<br \/>\nof this Agreement.<\/p>\n<p>     9.3  Amendment.  Subject to applicable law, this Agreement may be amended<br \/>\nby the parties hereto at any time by execution of an instrument in writing<br \/>\nsigned on behalf of each of the parties hereto; provided, however, execution by<br \/>\nthe Shareholder Agent shall only be required for amendments relating to Article<br \/>\n8 hereof.<\/p>\n<p>     9.4  Extension; Waiver.  At any time prior to the Closing, Purchaser, FAS<br \/>\nand the Shareholders may, to the extent legally allowed, (i) extend the time for<br \/>\nthe performance of any of the obligations of the other party hereto, (ii) waive<br \/>\nany inaccuracies in the representations and warranties made to such party<br \/>\ncontained herein or in any document delivered pursuant hereto and (iii) waive<br \/>\ncompliance with any of the agreements or conditions for the benefit of such<br \/>\nparty contained herein. Any agreement on the part of a party hereto to any such<br \/>\nextension or waiver shall be valid only if set forth in an instrument in writing<br \/>\nsigned on behalf of such party.<\/p>\n<p>                                  ARTICLE 10.<\/p>\n<p>                              GENERAL PROVISIONS<\/p>\n<p>     10.1 Notices.  Every notice, consent and other communications required or<br \/>\npermitted to be given hereunder shall be in writing and shall be deemed given if<br \/>\ndelivered personally or by commercial messenger or courier service, or mailed by<br \/>\nregistered or certified mail (return receipt requested) or sent via facsimile<br \/>\n(with acknowledgment of complete transmission) to the parties at the following<br \/>\naddresses (or at such other address for a party as shall be specified by like<br \/>\nnotice), provided, however, that notices sent by mail will not be deemed<br \/>\nguaranteed received:<\/p>\n<p>                                     -42-<\/p>\n<p>     (a)  if to Purchaser to:<\/p>\n<p>               homestore.com, Inc.<br \/>\n               225 West Hillcrest Drive, Suite 100<br \/>\n               Thousand Oaks, CA 91360<br \/>\n               Attention: General Counsel<br \/>\n               Telephone No.:  (805) 557-2300<br \/>\n               Facsimile No.:  (805) 557-2689<\/p>\n<p>               with a copy to:<\/p>\n<p>               Wilson Sonsini Goodrich &amp; Rosati<br \/>\n               Professional Corporation<br \/>\n               650 Page Mill Road<br \/>\n               Palo Alto, California 94304<br \/>\n               Attention:  Martin W. Korman, Esq.<br \/>\n                           Bradley L. Finkelstein, Esq.<br \/>\n               Telephone No.:  (650) 493-9300<br \/>\n               Facsimile No.:   (650) 493-6811<\/p>\n<p>          (b)  if to FAS, CNI or the Shareholder Agent, to:<\/p>\n<p>               Central Newspapers, Inc.<br \/>\n               200 E. Van Buren Street<br \/>\n               Phoenix, Arizona 85004<br \/>\n               Attention: Thomas K. MacGillivray<br \/>\n               Telephone No.:  (602) 444-1122<br \/>\n               Facsimile No.:  (602) 444-8340<\/p>\n<p>               with a copy to:<\/p>\n<p>               Snell &amp; Wilmer L.L.P.<br \/>\n               One Arizona Center<br \/>\n               Phoenix, Arizona 85004<br \/>\n               Attention: Matthew P. Feeney, Esq.<br \/>\n               Telephone No.:  (602) 382-6000<br \/>\n               Facsimile No.:  (602) 382-6070<\/p>\n<p>          (c)  if to the Shareholders, to:<\/p>\n<p>                                     -43-<\/p>\n<p>               The address, telephone number and facsimile number set forth<br \/>\n               opposite such Shareholders name on Exhibit A hereto or if no<br \/>\n               address, telephone number or facsimile number is provided, to the<br \/>\n               Shareholder Agent.<\/p>\n<p>     10.2 Interpretation.  The words &#8220;include,&#8221; &#8220;includes&#8221; and &#8220;including&#8221; when<br \/>\nused herein shall be deemed in each case to be followed by the words &#8220;without<br \/>\nlimitation.&#8221; The word &#8220;knowledge&#8221; when used herein with respect to a corporation<br \/>\nmeans the actual knowledge of any of the officers or directors of the<br \/>\ncorporation. The table of contents and headings contained in this Agreement are<br \/>\nfor reference purposes only and shall not affect in any way the meaning or<br \/>\ninterpretation of this Agreement.<\/p>\n<p>     10.3 Counterparts.  This Agreement may be executed in one or more<br \/>\ncounterparts, all of which shall be considered one and the same agreement and<br \/>\nshall become effective when one or more counterparts have been signed by each of<br \/>\nthe parties and delivered to the other party, it being understood that all<br \/>\nparties need not sign the same counterpart.<\/p>\n<p>     10.4 Entire Agreement; Assignment. This Agreement, the Exhibits hereto, the<br \/>\nFAS Schedules and the Purchaser Schedules, and the documents and instruments and<br \/>\nother agreements among the parties hereto referenced herein: (a) constitute the<br \/>\nentire agreement among the parties with respect to the subject matter hereof and<br \/>\nsupersede all prior agreements and understandings both written and oral, among<br \/>\nthe parties with respect to the subject matter hereof; (b) are not intended to<br \/>\nconfer upon any other person any rights or remedies hereunder; and (c) may not<br \/>\nbe assigned unless agreed to by the other parties hereto, except that Purchaser<br \/>\nmay assign its rights and delegate its obligations hereunder to majority-owned<br \/>\nsubsidiaries of Purchaser provided that Purchaser remains contingently liable.<\/p>\n<p>     10.5 Severability. In the event that any provision of this Agreement or the<br \/>\napplication thereof, becomes or is declared by a court of competent jurisdiction<br \/>\nto be illegal, void or unenforceable, the remainder of this Agreement will<br \/>\ncontinue in full force and effect and the application of such provision to other<br \/>\npersons or circumstances will be interpreted so as reasonably to effect the<br \/>\nintent of the parties hereto. The parties further agree to replace such void or<br \/>\nunenforceable provision of this Agreement with a valid and enforceable provision<br \/>\nthat will achieve, to the extent possible, the economic, business and other<br \/>\npurposes of such void or unenforceable provision.<\/p>\n<p>     10.6 Other Remedies.  Except as otherwise provided herein, any and all<br \/>\nremedies herein expressly conferred upon a party will be deemed cumulative with<br \/>\nand not exclusive of any other remedy conferred hereby, or by law or equity upon<br \/>\nsuch party, and the exercise by a party of any one remedy will not preclude the<br \/>\nexercise of any other remedy.<\/p>\n<p>     10.7 Governing Law.  This Agreement shall be governed by and construed in<br \/>\naccordance with the laws of the State of California, regardless of the laws that<br \/>\nmight otherwise govern under applicable principles of conflicts of laws thereof.<br \/>\nEach of the parties hereto irrevocably consents to<\/p>\n<p>                                     -44-<\/p>\n<p>the non-exclusive jurisdiction and venue of any federal or state court within<br \/>\nthe Northern District, State of California, in connection with any matter based<br \/>\nupon or arising out of this Agreement or the matters contemplated herein, agrees<br \/>\nthat process may be served upon them in any manner authorized by the laws of the<br \/>\nState of California for such persons and waives and covenants not to assert or<br \/>\nplead any objection which they might otherwise have to such jurisdiction, venue<br \/>\nand such process.<\/p>\n<p>     10.8 Rules of Construction.  The parties hereto agree that they have been<br \/>\nrepresented by counsel during the negotiation and execution of this Agreement<br \/>\nand, therefore, waive the application of any law, regulation, holding or rule of<br \/>\nconstruction providing that ambiguities in an agreement or other document will<br \/>\nbe construed against the party drafting such agreement or document.<\/p>\n<p>     10.9 Attorneys&#8217; Fees.  If any action or other proceeding relating to the<br \/>\nenforcement of any provision of this Agreement is brought by any party hereto,<br \/>\nthe prevailing party shall be entitled to recover reasonable attorneys&#8217; fees,<br \/>\ncosts and disbursements (in addition to any other relief to which the prevailing<br \/>\nparty may be entitled).<\/p>\n<p>                 [REMAINDER OF PAGE INTENTIONALLY LEFT BLANK]<\/p>\n<p>                                     -45-<\/p>\n<p>     IN WITNESS WHEREOF, Purchaser, FAS, the Shareholders and, with respect to<br \/>\nArticle 8 only, the Shareholder Agent have caused this Agreement to be signed by<br \/>\ntheir duly authorized respective officers, all as of the date first written<br \/>\nabove.<\/p>\n<p>HOMESTORE.COM, INC.                     FAS-HOTLINE, INC.<\/p>\n<p>By:    \/s\/ Stuart Wolff                   By:  \/s\/ Richard Ganley<br \/>\n   ___________________________             ________________________________<\/p>\n<p>Title: C.E.O.                           Title: President<br \/>\n      ________________________                _____________________________<\/p>\n<p>SHAREHOLDERS<\/p>\n<p>CENTRAL NEWSPAPERS, INC.                RAMAS, L.P.<\/p>\n<p>By:    \/s\/ Louis A. Weil                By:    \/s\/ Richard Ganley<br \/>\n   ___________________________             ________________________________<br \/>\n                                               Richard Ganley,<br \/>\n                                               its General Partner<br \/>\nTitle: Chairman\/President\/C.E.O.<br \/>\n      ________________________          Address:  12110 E. Gold Dust Ave<br \/>\n                                                ___________________________<br \/>\n                                            Scottsdale, Arizona 85259<br \/>\n                                        ___________________________________<\/p>\n<p>                                        ___________________________________ <\/p>\n<p>                                        ___________________________________<\/p>\n<p>                                        Phone:     (480) 661-7515<br \/>\n                                              _____________________________<\/p>\n<p>                                        Facsimile: (480) 922-1108<br \/>\n                                                  _________________________<\/p>\n<p>                      ***FAS STOCK PURCHASE AGREEMENT***<\/p>\n<p>                                      S-1<\/p>\n<p>By: \/s\/ Bryan Schutjer                  By: \/s\/ Stephen Ziomek<br \/>\n   ______________________________           __________________<br \/>\n    Bryan Schutjer                           Stephen Ziomek<\/p>\n<p>Address:  11653 N. 129th Way            Address: 8390 E. Corrine Dr.<br \/>\n         _________________________      __________________________________<br \/>\nScottsdale, AZ 85259                    Scottsdale, AZ 85260<br \/>\n_________________________________       __________________________________<\/p>\n<p>_________________________________       __________________________________<\/p>\n<p>_________________________________       __________________________________<\/p>\n<p>Phone: (480) 451-6894                   Phone: (480) 483-6185<br \/>\n      ___________________________              ___________________________<\/p>\n<p>Facsimile: (480) 922-1108              Facsimile: (480) 922-1108<br \/>\n          _______________________                _________________________<\/p>\n<p>SHAREHOLDER AGENT<\/p>\n<p>CENTRAL NEWSPAPERS, INC.<\/p>\n<p>By:  \/s\/ Louis A. Weil<br \/>\n   ______________________________<\/p>\n<p>Title: Chairman\/President\/C.E.O.<br \/>\n      ___________________________<\/p>\n<p>                      ***FAS STOCK PURCHASE AGREEMENT***<\/p>\n<p>                                      S-2<\/p>\n","protected":false},"template":"","meta":{"_acf_changed":false,"_stopmodifiedupdate":true,"_modified_date":"","_cloudinary_featured_overwrite":false},"corporate_contracts_companies":[7788],"corporate_contracts_industries":[9486],"corporate_contracts_types":[9622,9627],"class_list":["post-43681","corporate_contracts","type-corporate_contracts","status-publish","hentry","corporate_contracts_companies-homestorecom-inc","corporate_contracts_industries-real__agents","corporate_contracts_types-planning","corporate_contracts_types-planning__purchase"],"acf":[],"_links":{"self":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts\/43681","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts"}],"about":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/types\/corporate_contracts"}],"wp:attachment":[{"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/media?parent=43681"}],"wp:term":[{"taxonomy":"corporate_contracts_companies","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_companies?post=43681"},{"taxonomy":"corporate_contracts_industries","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_industries?post=43681"},{"taxonomy":"corporate_contracts_types","embeddable":true,"href":"https:\/\/corporate.findlaw.com\/legal-api\/wp-json\/wp\/v2\/corporate_contracts_types?post=43681"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}